<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Transglutaminases in disease</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Soo-Youl</forename><surname>Kim</surname></persName>
							<email>sykim@burke.org</email>
							<affiliation key="aff0">
								<orgName type="laboratory">Laboratory of Skin Biology</orgName>
								<orgName type="institution">NIAMS</orgName>
								<address>
									<region>NIH, MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Weill Medical College</orgName>
								<address>
									<addrLine>Cornell Uni6ersity</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Burke Medical Research Institute</orgName>
								<address>
									<addrLine>785 Mamaroneck A6enue</addrLine>
									<postCode>10605</postCode>
									<settlement>White Plains</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">M</forename><surname>Jeitner</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Weill Medical College</orgName>
								<address>
									<addrLine>Cornell Uni6ersity</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Burke Medical Research Institute</orgName>
								<address>
									<addrLine>785 Mamaroneck A6enue</addrLine>
									<postCode>10605</postCode>
									<settlement>White Plains</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Laboratory of Skin Biology</orgName>
								<orgName type="institution">NIAMS</orgName>
								<address>
									<region>NIH, MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Transglutaminases in disease</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">6A1E88FE1BF175D0231A2A8001E763ED</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Transglutaminases</term>
					<term>Disease</term>
					<term>Alzheimer&apos;s disease</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Transglutaminases (TGases) are enzymes that are widely used in many biological systems for generic tissue stabilization purposes. Mutations resulting in lost activity underlie several serious disorders. In addition, new evidence documents that they may also be aberrantly activated in tissues and cells and contribute to a variety of diseases, including neurodegenerative diseases such as Alzheimer's and Huntington's diseases. In these cases, the TGases appear to be a factor in the formation of inappropriate proteinaceous aggregates that may be cytotoxic. In other cases such as celiac disease, however, TGases are involved in the generation of autoantibodies. Further, in diseases such as progressive supranuclear palsy, Huntington's, Alzheimer's and Parkinson's diseases, the aberrant activation of TGases may be caused by oxidative stress and inflammation. This review will examine the role and activation of TGases in a variety of diseases.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>Transglutaminases (TGases) are particularly interesting enzymes to consider in the context of pathology because their many functions generally involve either protection and prevention of bodily injury, or tissue assembly and repair. TGases can be thought of as mediators of biological glues. Their most common function is to catalyze the formation of isopeptide linkages between the carboxamide group of proteinbound glutamine residues and the o-amino group of protein-bound lysine residue. 1 Thus, one of the TGase isoforms -factor XIIIa -catalyzes the formation of blood clots and thereby repairs potentially life-threatening injury. TGase 1 cross links the proteins that comprise the cell envelope, a flexible insoluble barrier that lines the outer surface of fully differentiated cells of stratified squamous epithelia, which thereby protects against mechanical and chemical injury, or dehydration in the case of cornified epidermal cells. Similar roles have been ascribed to several other TGase isoforms in epithelia, including TGases 3-7. Supporting the thesis that TGases are critically important to facilitate tissue protective functions is the observation that ancestral forms of these enzymes occur early in evolution <ref type="bibr" target="#b1">(Aeschlimann and Paulsson, 1994)</ref>. Further, convergent evolution has produced similar enzymes in bacteria <ref type="bibr" target="#b105">(Kanaji et al., 1993;</ref><ref type="bibr" target="#b162">Pasternack et al., 1998)</ref>.</p><p>It is now appreciated that TGases are normally expressed at low levels in many different tissues. Further, it is becoming apparent that TGases are inappropriately activated in a variety of pathologies. With the exception of the diseases involving TGase mutations, however, it is not clear what role TGases are specifically playing in disease etiology. Thus, our purpose in reviewing the pathologies that involve TGases is to understand the common and specific roles of TGases in disease.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Protective roles of TGases in epithelia</head><p>One of the major functions of TGases in epithelia is the formation of a cell envelope (CE) barrier structure, which is a complex amalgam of proteins that lines the exterior of the cell and replaces the plasma membrane of the fully differentiated cell. Indeed, seven of the nine known TGase enzymes are active in such tissues and several are now known to directly play consecutive and complementary roles in CE formation. In the specialized case of the cornified epidermis, the CE is composed of two parts: a highly insoluble protein envelope about 10 nm thick and of uniform mass density (about 7 kDa/nm 2 ) and a lipid envelope about 5 nm thick composed of covalently attached ceramide lipids that coats the exterior of the cell <ref type="bibr" target="#b192">(Steinert, 2000)</ref>. This composite structure provides vital physical and mechanical barrier properties to the epidermal cells, but has little or no water barrier function by itself. This is provided together with a complex array of intercellular lipids, which stack in organized lamellae layers that are themselves organized by the ceramide lipids attached on the surface of the cell. This interplay between the CE and the intercellular lipids affords effective physical, mechanical, chemical and water barrier function.</p><p>CE precursor proteins widely used in epithelia include envoplakin, periplakin, involucrin, and various members of the numerous small proline-rich family of proteins. Starting at interdesmosomal sites, these become cross-linked together by several TGase isoforms to form a scaffold. Each specialized epithelium then uses these and/or other proteins to form the reinforced mature CE typical of a given tissue; e.g. in the epidermis, the major reinforcement protein is loricrin <ref type="bibr">(Nemes and Steinert, 1999;</ref><ref type="bibr" target="#b193">Steinert and Marekov, 1999)</ref>. Direct evidence has now shown that cytosolic TGases, including in particular TGase 3, are responsible for cross-linking various soluble CE proteins into small oligomers. These are then translocated to the cell periphery where they become cross-linked to the growing CE structure by the membrane-anchored TGase 1 enzyme <ref type="bibr" target="#b111">(Kim et al., 1995;</ref><ref type="bibr" target="#b194">Steinert et al., 1998)</ref>. Both TGases 1 and 3 require proteolytic activation at specific sequence sites. In both cases, there is a 100-1000-fold increase in enzyme specific activity upon maximal activation <ref type="bibr" target="#b110">(Kim et al., 1994)</ref>. While there is some evidence that calpain is involved <ref type="bibr" target="#b108">(Kim and Bae, 1998)</ref>, the details of these activation processes remain to be elucidated. In addition, in the epidermis, it is now known that the TGase 1 enzyme can catalyze the formation of ester bonds between the ceramides and the CE proteins envoplakin, periplakin and involucrin <ref type="bibr">(Nemes et al., 1999)</ref>. The enzyme mechanism is identical to cross link formation, except that an -OH group on the ceramides serves as the nucleophile.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Lamellar ichthyosis</head><p>Given the role of TGases in skin development it would be expected that loss or gain of TGase activity should result in pathology <ref type="bibr" target="#b202">(Van Hooijdonk et al., 1991)</ref>. Indeed, mutations in TGase 1 are responsible for a major form of autosomal recessive ichthyosis, termed lamellar ichthyosis, a disorder of keratinization. This disease occurs spontaneously at a frequency of between 1 and 3× 10 5 individuals. The affected individuals are born embedded in hyperkeratotic skin (collodion-baby syndrome), which later cracks and exposes the underlying tissue, leading to life-threatening dehydration and systemic infections. If the newborn survives the first few months of life, the disease eventually develops into large brown plate-like scales, which cover the entire body surface. In addition, there are numerous other autosomal ichthyoses, some of which might be caused by interference of TGase 1 function. One of these is X-linked ichthyosis, caused by the loss of the cholesterol sulfatase gene, and results in an excessive accumulation of cholesterol sulfate in the skin. Cholesterol sulfate is a known competitive inhibitor of TGase 1 function. It appears to allow greater access of water to the active site, resulting in deamidation of activated glutamine residues rather than reaction to form esters or isopeptide cross-links <ref type="bibr">(Nemes et al., 1999)</ref>. Interestingly, lamellar ichthyosis affects only the epidermis: other internal 'wet' epithelia, which also abundantly express the TGase 1 enzyme isoform, but do not form a ceramide lipid envelope, are not notably affected. This observation suggests that TGase 1 is perhaps more important for ceramide attachment to proteins by ester formation than for cross-linking CE proteins, a function which perhaps can be replaced by the other TGase isoforms active in the skin. As TGase 1 is the only enzyme isoform known to be associated with membranes, this may explain lamellar ichthyosis disease extent and severity. Cases of lamellar ichthyosis may be homozygous or compound heterozygous, and involve deletions or insertions that result in a nonsense protein, or a truncated protein due to premature chain termination, or splicing errors <ref type="bibr" target="#b93">(Huber et al., 1995;</ref><ref type="bibr" target="#b178">Russell et al., 1995;</ref><ref type="bibr" target="#b164">Petit et al., 1997)</ref>. The \ 20 known TGase 1 mutations occur randomly throughout the gene and suggest that there are no particular mutational hot spots associated with lamellar ichthyosis <ref type="bibr" target="#b187">(Shevchenko et al., 2000)</ref>. Not all TGase 1 mutations, however, inactivate the enzyme outright. For example, <ref type="bibr" target="#b33">Candi et al. (1998)</ref> identified two mutant forms of TGase 1 in lamellar ichthyosis that have somewhat increased enzyme stability, which ultimately however, interfered with proteolytic activation for optimal enzyme activity and function.</p><p>In addition, there are other forms of autosomal ichthyoses clinically similar to lamellar ichthyosis that are not linked to the TGM1 gene locus: four separate loci have been identified that are not linked to the genes for TGase 1, 2 or 3 <ref type="bibr" target="#b14">(Bale et al., 1996;</ref><ref type="bibr" target="#b161">Parmentier et al., 1996;</ref><ref type="bibr" target="#b63">Fischer et al., 2000)</ref>. Some of these might be caused by mutations in genes whose products are re-quired to process the TGase 1 enzyme into its active form (such as proteases or lipid acyltransferases). Further, the possibility exists that mutations in other TGM genes might cause pathology. However, experimental knockout of the TGM2 gene has no notable phenotype in mice <ref type="bibr" target="#b52">(De Laurenzi and Melino, 2001)</ref>: does this mean that mutations of this gene do not cause pathology in humans? On the other hand, knockout of the TGM3 gene results in very early embryonic lethality in mice (L. Milstone, personal communication): does this too mean that mutations in this gene will not be found in humans? Finally, it is not proven yet whether any cases of ichthyoses result from significantly elevated TGase activity, but this remains a possibility.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Factor XIIIa deficiency</head><p>Factor XIIIa is the TGase isoform that is important for the clotting of blood. In the process of clotting, factor XIIIa catalyzes the formation of o(g-glutamyl)lysine cross-links between fibrin monomers or fibrin and a 2 -plasmin inhibitor. Factor XIIIa is activated by proteolytic cleavage of its proenzyme form, factor XIII. The proteolytic activation of factor XIIIa is mediated by thrombin, in response to Ca 2 + released from platelets at the site of vascular leakage <ref type="bibr" target="#b94">(Ichinose et al., 1986a)</ref>.</p><p>Factor III is a tetramer composed of two A and two B subunits. The A subunit contains the active TGase enzyme and the B subunit is thought to stabilize the overall enzyme complex. In addition to its structural role, the B subunit also contains ten tandem repeats that resemble the GPI structure or Sushi domains <ref type="bibr" target="#b95">(Ichinose et al., 1986b)</ref>. These domains have been found in more that thirty other proteins and are hypothesized to be important for proteinprotein interactions.</p><p>As expected, deficiencies in factor XIIIa activity cause protracted bleeding. At present, bleeding disorders due to factor XIIIa deficiency occur at a frequency of 1-in-5×10 6 individuals in Japan <ref type="bibr" target="#b88">(Hashiguchi et al., 1993;</ref><ref type="bibr" target="#b43">Coggan et al., 1995;</ref><ref type="bibr" target="#b191">Souri et al., 1998;</ref><ref type="bibr" target="#b197">Takahashi et al., 1998)</ref>. These disorders are classified into two types: type I where both the A and B subunits are mutated, or type II in which the A subunit only is mutated. At present \30 different mutations have been described for factor XIIIa deficiency, and these too are scattered along the entire length of the gene. Since mutations in the B subunit contribute to factor XIIIa deficiency it will be important to discern the functions of this subunit and how these functions impinge on factor XIIIa activity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Celiac disease: autoimmunity and TGases</head><p>TGase antibodies have been found in a number of autoimmune diseases, which suggests the possibility that the inappropriate presentation of TGases to T cells might contribute to these diseases. The immune system has evolved elaborate defenses against the development of autoimmunity and consequently, a reaction against self components usually reflects the aberrant activation of numerous effectors of immunity. Celiac disease will be used as an example here to show how the various parts of the immune system can contribute to autoimmunity.</p><p>Celiac disease is characterized by damage to the upper small intestine, causing effacement of the villi to produce a characteristically flat mucosa with markedly hypertrophic crypts <ref type="bibr" target="#b201">(Trier 1991;</ref><ref type="bibr" target="#b135">Marsh, 1992)</ref>. Consequently, patients with celiac disease usually have difficulty with absorption. The incidence of frank celiac disease ranges from 1:300 in Western Ireland to 1:4700 in other European countries <ref type="bibr" target="#b152">(Mylotte et al., 1973;</ref><ref type="bibr" target="#b181">Sandforth et al., 1991)</ref>, whereas the frequency of nonsymptomatic celiac disease has been estimated to be as high as 3.3 and 4 per 1000 in Italy and the USA, respectively <ref type="bibr" target="#b36">(Catassi et al., 1994;</ref><ref type="bibr">Not et al., 1998)</ref>. Celiac disease is precipitated by the ingestion of gliadin, a proteinaceous component of wheat gluten. The disease is found in genetically predisposed individuals (mostly HLA-DQ2 and -DQ8 positive) who mount heightened T cell-mediated and humoral immune responses to gluten, the protein found in wheat, rye, and barley flours. The immunological reaction to gliadin (alcohol fraction of gluten) in the upper small bowel, where ingested dietary components are concentrated, leads to inflammation and the characteristic features of disease <ref type="bibr" target="#b135">(Marsh, 1992)</ref>. The disorder is now considered to result from a complex interplay of genetic and variable environmental factors in order to explain the wide spectrum of clinical manifestations ranging from asymptomatic to severe malabsorption.</p><p>The pathogenesis of CD has recently made rapid progress since the discovery that TGase 2 is an autoimmune antigen of celiac disease <ref type="bibr" target="#b56">(Dieterich et al., 1997)</ref>. Active celiac disease is accompanied by mucosal autoantibodies to reticulin, a common component of the extracellular matrix. Antireticulin antibodies are identical to antiendomysial autoantibodies that allow a screening for biopsy-proven celiac disease with 100% specificity <ref type="bibr" target="#b47">(Corrao et al., 1994)</ref>. Immunoprecipitation of proteins from fibrosarcoma cells with IgA from celiac disease patients led to the identification of TGase 2 as the dominant endomysial autoantigen <ref type="bibr" target="#b56">(Dieterich et al., 1997)</ref>.</p><p>Thus the questions is, how does autoimmunity arise? Based on a series of in vitro experiments, TGase 2 is thought to be responsible for generating neoepitopes of gliadin through deamidation of glutamine residues. HLA-DQ molecules have low affinity for unmodified peptides derived from gliadin <ref type="bibr">(Johansen et al., 1996a,b)</ref>. However, TGase 2 treatment in vitro significantly increases the ability of gliadin fragments to stimulate the proliferation of gliadin-specific T cells <ref type="bibr" target="#b146">(Molberg et al., 1998b;</ref><ref type="bibr" target="#b203">Van de Wal et al., 1998)</ref>. Mass spectrometric measurements have demonstrated that the effect of TGase is to deamidate the gliadin peptides <ref type="bibr" target="#b146">(Molberg et al., 1998b;</ref><ref type="bibr" target="#b203">Van de Wal et al., 1998)</ref>. Similar increases in the antigenicity of the gliadin peptides were also obtained by acid-induced deamidation <ref type="bibr" target="#b146">(Molberg et al., 1998b)</ref>. The deamidation converts glutamines to negatively-charged glutamic acid residues, which in turn increases the affinity for binding sites on HLA-DQ2 and DQ8 <ref type="bibr" target="#b145">(Molberg et al., 1998a;</ref><ref type="bibr" target="#b188">Sjostrom et al., 1998;</ref><ref type="bibr" target="#b203">Van de Wal et al., 1998;</ref><ref type="bibr" target="#b8">Arentz-Hansen et al., 2000)</ref>. Both HLA-DQ2 and DQ8 preferentially bind negatively-charged peptides <ref type="bibr" target="#b101">(Johnson et al., 1997;</ref><ref type="bibr" target="#b120">Kwok et al., 1996)</ref>. Interestingly, only T cells derived from the gut of disease patients respond to TGase-modified gliadin peptides. This attests to the organ-specific nature of this disease <ref type="bibr" target="#b146">(Molberg et al., 1998b;</ref><ref type="bibr" target="#b203">Van de Wal et al., 1998)</ref>.</p><p>TGase 2 also cross-links itself onto gliadin in vitro, and it has been suggested that in vivo the cross-linked TGase might act as a hapten for the formation of antibodies against gliadin <ref type="bibr" target="#b167">(Porta et al., 1991;</ref><ref type="bibr" target="#b146">Molberg et al., 1998b;</ref><ref type="bibr" target="#b203">Van de Wal et al., 1998)</ref>. This is a plausible hypothesis because serum anti-TGase antibody titer falls dramatically when wheat products are removed from the diet. Thus, the presentation of fragments of gliadin cross-linked to TGase 2 results in antibodies against gliadin, TGase 2 and the cross-linked proteins. The greater preponderance of anti-TGase antibodies <ref type="bibr" target="#b56">(Dieterich et al., 1997;</ref><ref type="bibr" target="#b185">Schuppan et al., 1998)</ref> presumably reflects the greater antigenicity of this antigen.</p><p>The possibility of deamidation of gliadin by TGase 2 has been cited as the first example of an enzymicallygenerated neoepitope in an autoimmune disease <ref type="bibr" target="#b146">(Molberg et al., 1998b;</ref><ref type="bibr" target="#b203">Van de Wal et al., 1998)</ref>. Despite the elegance of this hypothesis, it is problematic because it is not yet clear how this might occur in vivo because TGase 2 would be acting on gliadin in an environment bereft of amine donors. The experiments demonstrating the antigenicity of TGase-treated gliadin peptides were performed using TGase 2 in the absence of amine donors. One possibility based on in vitro assays is that amine groups on the surface of TGase 2 molecules could serve as nucleophiles. Alternatively, water is the most abundantly available nucleophile, which would result in deamidation. It is also possible that gliadin is deamidated by the strong acids in the stomach. Glutamine comprises approximately 40% of the amino acids of gliadin. Thus, it would be expected that some of these glutaminyl residues would be spared from acidic deamidation to serve as carboxamide donors for the formation of o(g-glutamyl)lysine bonds by TGase 2. How TGase 2 comes in contacts with gliadin remains an interesting question. Compelling data do not yet exist to support the hypothesis that TGase 2 acts as a deaminase of gliadin in vivo, so this area remains an intriguing avenue for further research.</p><p>TGase 2 expression in jejunal biopsies of celiac disease patients is elevated by 3.2-fold <ref type="bibr" target="#b31">(Bruce et al., 1985)</ref> and it is theoretically possible this contributes to celiac disease by increasing the frequency of gliadin-TGase 2 cross-linking and/or deamidation. However, the source of the increased activity is not yet clear, although endothelial, fibroblast, and mononuclear cells may be the possible rich sources of TGase 2. In addition, stimulation by proinflammatory cytokines is a possible novel mechanism. The inflammatory infiltrates of the jejunal tissues of celiac disease patients are rich in T cells <ref type="bibr" target="#b145">(Molberg et al., 1998a)</ref>. Of these cells, it is the T helper cells (CD4 + ) that respond to deamidated gliadin <ref type="bibr" target="#b146">(Molberg et al., 1998b;</ref><ref type="bibr" target="#b203">Van de Wal et al., 1998)</ref>. T helper (Th) cells are separated into three groups based on the cytokines they secrete. Th1 cells predominantly produce interferon g (INF-g), tumor necrosis factor a (TNF-a) and interleukin 2 (IL-2), whereas Th2 cells produce IL-3, IL-4, IL-5, IL-10 and IL-13, and both of these cells are derived from Th0 which secrete a combination of these cytokines. Gluten-specific T cell clones from celiac disease patients secrete cytokines that are consistent with a Th0 cytokines, including significant quantities of INF-g <ref type="bibr" target="#b157">(Nilsen et al., 1998)</ref>. T cells are not the only source of cytokines as duodenal biopsies from celiac disease patients show increases in INF-g of greater than a 1000-fold relative to samples from normal individuals <ref type="bibr" target="#b157">(Nilsen et al., 1998)</ref>. Elevations in IL-2, IL-4, IL-6 and TNF-a have also been reported in the celiac disease patients <ref type="bibr" target="#b157">(Nilsen et al., 1998)</ref>.</p><p>Recently, <ref type="bibr">Kim and Steinert (2001)</ref> have shown that INF-g can induce expression of TGase 2 in the rat IEC-6 small intestinal cells, and interestingly, TGF-b suppresses TGase 2 expression in that system. Therefore, it was suggested that the increased expression of TGase 2 leading to pathogenesis of celiac disease in genetically predisposed individuals (HLA-DQ2 + ) could be due to increased IFN-g signaling, loss of TGF-b signaling, or both, in the small intestine.</p><p>Cytokine imbalance is a major contributor to the development of autoimmune disease and reflects an inability of T cells to resolve the disease. For example, INF-g stimulates the cell surface expression of HLA II molecules and thereby the inadvertent expression of neoantigens. IL-2 promotes T cell proliferation and can thereby stimulate the clonal expansion of self-reactive T cell clones. The expression of both of these cytokines is elevated in celiac disease <ref type="bibr" target="#b157">(Nilsen et al., 1998)</ref>.</p><p>Taken together, the above observations suggest that TGase 2 is involved in the pathogenesis of celiac disease, but more work is necessary to ascertain whether its role is direct or indirect.</p><p>Patients with celiac disease are also prone to other autoimmune diseases including dermatitis herpetiformis <ref type="bibr" target="#b172">(Reunala and Collin, 1997)</ref> and type 1 diabetes <ref type="bibr" target="#b16">(Bao et al., 1999)</ref>. Interestingly, autoantibodies against TGase 2 are also found in the blood of dermatitis herpetiformis <ref type="bibr" target="#b172">(Reunala and Collin, 1997;</ref><ref type="bibr" target="#b57">Dieterich et al., 1999)</ref> and type 1 diabetes patients <ref type="bibr" target="#b16">(Bao et al., 1999;</ref><ref type="bibr" target="#b122">Lampasona et al., 1999)</ref>. Dermatitis herpetiformis is characterized by blistering of the extensor surfaces and a sensitivity to gluten. Thus, the presence of anti-TGase 2 antibodies in celiac disease and dermatitis herpetiformis may reflect a common etiology. In addition, the antibodies in dermatitis herpetiformis may arise in a similar manner to that described above for celiac disease. Consistent with this view is the observation that the anti-TGase 2 antibodies found in dermatitis herpetiformis are mainly of the IgG class. The IgA immunoglobulins are predominantly associated with the external secretions including those of the digestive tract.</p><p>The anti-TGase 2 antibodies found in type 1 diabetes belong to the IgG and IgA immunoglobulin classes, which suggests that these antibodies arise by multiple mechanisms. Some diabetics with IgA anti-TGase antibodies also have celiac disease, although the disease is usually asymptomatic <ref type="bibr" target="#b122">(Lampasona et al., 1999)</ref>. The patients with celiac disease and type 1 diabetes are also usually homozygous for HLA-DQ2 <ref type="bibr" target="#b16">(Bao et al., 1999)</ref>, and this may be the major factor that drives the production of anti-TGase 2 antibodies. While approximately 8% of diabetics are positive for IgM anti-TGase 2 antibodies, a striking 42% of patients have IgG TGase 2 antibodies <ref type="bibr" target="#b122">(Lampasona et al., 1999)</ref>. IgG is the major circulating immunoglobulin, which suggests that the IgG anti-TGase 2 is generated by a different mechanism from that of the major IgM anti-TGase 2 found in celiac disease. <ref type="bibr" target="#b122">Lampasona et al. (1999)</ref> have proposed the following mechanisms for the generation of the IgG antibodies. First, Type 1 diabetics have increased intestinal permeability <ref type="bibr" target="#b119">(Kuitunen et al., 1994)</ref>, which may allow immunization against TGase 2 by cells from the systemic and gastric circulation. Second, diabetes is initiated by the destruction of pancreatic b cells, which might release TGase 2 as a neoepitope. This possibility is supported by the observation that successful management of the diabetes, which attenuates b cell destruction, results in decreased anti-TGase 2 titers <ref type="bibr" target="#b122">(Lampasona et al., 1999)</ref>. Alternatively, based on in vitro data, TGase 2 may cross-link the typical autoantigens for diabetes, such as insulin, glutamate decarboxylase and IA-2 <ref type="bibr" target="#b13">(Bach, 1994)</ref>, which if occurred in vivo, may then be presented to the appropriate T cells for immunization. Of the autoantigens commonly seen in diabetes, the acetylated B chain of oxidized insulin is a carboxamide donor for TGase 2 <ref type="bibr" target="#b65">(Folk and Finlayson, 1977)</ref>. Thus, it is further possible that the antigens for the production of IgG anti-TGase 2 antibodies are TGase 2-cross-linked to insulin or another autoantigen. This possibility is also consistent with the suggestion of <ref type="bibr" target="#b146">Molberg et al. (1998b)</ref> that TGase 2 acts as a hapten in the generation of antibodies against gliadin.</p><p>Given the above observations, we would like to suggest that TGase 2 generates autoantibodies in a variety of autoimmune disorders by cross-linking potential autoantigens and acting as a hapten. This hypothesis is supported by numerous reports showing that the participation of TGase substrates in autoimmune diseases (Table <ref type="table" target="#tab_0">1</ref>). In addition, anti-TGase 2 antibodies have been reported in lupus <ref type="bibr" target="#b179">(Sanchez et al., 2000)</ref>. TGase 2 has been detected in the synovial fluid of arthritis patients <ref type="bibr" target="#b208">(Weinberg et al., 1991)</ref>, and the serum and cerebral spinal fluid of amyotrophic lateral sclerosis patients <ref type="bibr" target="#b67">(Fujita et al., 1998)</ref> (Table <ref type="table" target="#tab_0">1</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.">Inclusion body myositis</head><p>Inclusion body myositis is the most common progressive muscle disorder that affects older individuals. This disease is characterized by a progressively worsening weakness in the proximal and distal limbs that is resistant to steroid therapy <ref type="bibr" target="#b35">(Carpenter, 1996)</ref>. The histological features of this disease include distinctive rimmed vacuoles and filamentous inclusions, as well as mononuclear infiltrates, which consist predominantly of cytotoxic T cells (CD8 + ) <ref type="bibr" target="#b142">(Miller et al., 1990;</ref><ref type="bibr">Rider et al., 1997)</ref>. Interestingly, the rimmed vacuoles consist of b-amyloid protein polymers, which in some ways are reminiscent of the cross-linked b-amyloid found in the brains of patients with Alzheimer's disease <ref type="bibr" target="#b137">(Masters et al., 1985;</ref><ref type="bibr" target="#b112">Kim et al., 1999)</ref>. <ref type="bibr" target="#b12">Askanas et al. (1993)</ref> hypothesized that the overexpression of the b-amyloid precursor protein and its abnormal deposition may precipitate the muscle-fiber destruction characteristic of inclusion body myositis. This hypothesis further suggested a role for TGases in inclusion body myositis based of the putative involvement of these enzymes in the formation of the b-amyloid aggregates in Alzheimer's disease (see Section 9 below). Total TGase enzyme activity is elevated by 16-fold in diseased tissue, which is reflected in an increased number of o(g-glutamyl)lysine cross-links to 60/10 000 residues from 2/10 000 in normal muscle <ref type="bibr" target="#b41">(Choi et al., 2000)</ref>. This activity is ostensibly due to the increased expression of TGase 1 and 2 mRNAs, because the expression of these mRNAs is elevated by 2.5-and 4-fold, respectively, in diseased tissues <ref type="bibr" target="#b41">(Choi et al., 2000)</ref>. Finally, TGase 1 and 2 co-localize with amyloid deposits in vacuolated muscle fibers from patients with inclusion body myositis <ref type="bibr" target="#b41">(Choi et al., 2000)</ref>. The chronic inflammation that characterizes inclusion body myositis may also stimulate the expression of TGases 1 and 2 and thereby contribute to the progressive nature of this disease. This myositis is considered to be an autoimmune disease and is associated with the expression of specific HLA molecules and a variety of autoantibodies <ref type="bibr" target="#b131">(Love et al., 1991;</ref><ref type="bibr">Rider et al., 1997;</ref><ref type="bibr" target="#b115">Koffman et al., 1998)</ref>. In addition, the Th1 to Th2 balance in patients with myositis is shifted in favor of the Th1 cells and results in an excess production of INF-g and TNF-a <ref type="bibr" target="#b133">(Lungderg et al., 1995)</ref>. These cytokines are also produced by macrophages and the injured muscle cells in the diseased tissue. As described above for celiac disease, INF-g and TNF-a stimulate the expression of TGase 2 <ref type="bibr">(Kim and Steinert, 2001;</ref><ref type="bibr">Kim et al., 2001)</ref>. Moreover, INF-g and TNF-a stimulate TGase expression in myoblasts <ref type="bibr">(Kim et al., 2001)</ref>. Thus, myositis may result following the development of autoimmunity. The subsequent production of proinflammatory cytokines may then stimulate the expression of TGases, which in turn polymerize b-amyloid in the affected muscle, causing a progressive pathology.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7.">Cataract formation</head><p>A cortical cataract is an opacification of the eye and is a significant cause of blindness. The opacification results from the aberrant cross-linking of predomi-nantly b-crystallin in the outer epithelial layers of the cornea. There are a number of compelling observations that indicate a pivotal role for TGases in the cataract development. Cataracts are distinguished by a marked elevation of intracellular Ca 2 + (Ca 2 + i ). Other ionic disturbances also occur, such as increases in Na + and decreases in K + , but the increase in Ca 2 + i is considered to be the major contributor to cataractogenesis <ref type="bibr" target="#b180">(Sanderson et al., 2000)</ref>. The elevation of Ca 2 + i may act to stimulate TGase activity either directly or indirectly. It is well established that Ca 2 + activates TGases in vitro <ref type="bibr" target="#b65">(Folk and Finlayson, 1977)</ref>. <ref type="bibr" target="#b214">Zhang et al. (1998b)</ref> have extended this observation by using a unique assay for in situ TGase activity, to show that intracellular TGases are activated by elevations of Ca 2 + i . <ref type="bibr" target="#b129">Lorand et al. (1985</ref><ref type="bibr">Lorand et al. ( , 1998) )</ref> have further shown that treatment of rabbit eye lens with the calcium ionophore ionomycin, promotes the formation of b-crystallin dimers that resemble those produced in vitro with TGase and b-crystallin. These observations suggest that TGases may be activated during cataractogenesis. Nevertheless, to the knowledge of the authors, o(g-glutamyl)lysine crosslinked proteins have not yet been identified in cataracts. The latter would constitute strong evidence in favor for the involvement of TGases in cataract formation.</p><p>Calpain is a calcium-dependent protease that proteolytically activates TGase 1 in vivo <ref type="bibr" target="#b6">(Ando et al., 1988;</ref><ref type="bibr" target="#b108">Kim and Bae, 1998;</ref><ref type="bibr" target="#b213">Zhang et al., 1998a)</ref>. For example, calpain inhibitors prevent the formation of the epidermal cornified cell envelope by blocking the proteolytic processing of TGase 1 <ref type="bibr" target="#b108">(Kim and Bae, 1998)</ref>. One of the features of cataract formation is a significant loss of lens dry weight and this loss of protein correlates with the ionic disturbance of the lens <ref type="bibr" target="#b180">(Sanderson et al., 2000)</ref>. Calpain is also thought to be one of the proteases activated during cataractogenesis, because one of its cleavage products, vimentin, has been identified in ionomycin-treated lenses <ref type="bibr" target="#b130">(Lorand et al., 1998;</ref><ref type="bibr" target="#b180">Sanderson et al., 2000)</ref>. Because TGase 1 is also a substrate for this enzyme, calpain-mediated proteolysis may be another path for the activation of TGase 1. TGase 2, however, loses activity after the calpain activation indicating that the majority of the increase in TGase activation seen following Ca 2 + may be due to TGase 1. This may have important implications for the proteins that are cross-linked, since those proteins normally cross-linked by TGase 2 may be linked to different substrates by TGase 1. These potentially novel aggregates may be pathogenic.</p><p>Finally, it is generally agreed that oxidative stress is an important factor in the development of cataract <ref type="bibr" target="#b23">(Boscia et al., 2000)</ref>. Oxidative stress and reactive oxygen intermediates have been shown to increase the expression of TGase 2 <ref type="bibr" target="#b144">(Mirza et al., 1997)</ref>, which could enhance phospholipase A2 activity by intra-molecular cross-linking <ref type="bibr" target="#b46">(Cordella-Miele et al., 1993)</ref> and thereby stimulating further free radical production via arachidonic acid metabolism <ref type="bibr" target="#b37">(Chan and Fishman, 1980)</ref>. Oxidative stress may also activate TGases by elevating Ca 2 + i or decreasing cellular GTP levels <ref type="bibr" target="#b5">(Andersson et al., 1998)</ref>. TGase activity is functionally related to cellular GTP levels <ref type="bibr" target="#b214">(Zhang et al., 1998b)</ref>. Johnson and coworkers have demonstrated that the induction of an oxidative stress that originates in the mitochondria stimulates in situ TGase activity <ref type="bibr" target="#b128">(Lesort et al., 2000)</ref>. This stimulation appears to be due to the loss of GTP rather than an increase in Ca 2 + i . However, the major source of reactive oxygen species in the eye is likely to be UV radiation rather than mitochondrial dysfunction. UV radiation generates singlet oxygen and superoxide in the eye <ref type="bibr" target="#b85">(Halliwell and Gutteridge, 1989)</ref>. Superoxide rapidly dismutates to hydrogen peroxide, which elevates Ca 2 + i <ref type="bibr" target="#b71">(Gibson et al., 2001)</ref>. Therefore, it is possible that changes in Ca 2 + i observed in the eye are due to long-term UV exposure and that these changes activate TGases. The generation of reactive oxygen species is likely to generate oxidized (and thus denatured) proteins that may have a greater ability to act as substrates for TGases <ref type="bibr" target="#b81">(Groenen et al., 1993)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.">Atherosclerosis</head><p>TGases are involved in the stabilization of the extracellular matrix by cross-linking matrix proteins. TGase 2 is associated with extracellular surfaces, although the mechanism by which this protein traverses plasmalemma membranes is not known <ref type="bibr" target="#b150">(Muesch et al., 1990)</ref>. A number of the major matrix proteins have been identified as TGase substrates including fibronectin <ref type="bibr" target="#b198">(Tamaki and Aoki, 1981;</ref><ref type="bibr" target="#b148">Mosher et al., 1991)</ref>, fibrinogen <ref type="bibr" target="#b38">(Chen and Doolittle, 1971;</ref><ref type="bibr" target="#b49">Cottrell et al., 1979;</ref><ref type="bibr" target="#b82">Guadiz et al., 1997)</ref>, osteonectin <ref type="bibr" target="#b3">(Aeschlimann et al., 1995;</ref><ref type="bibr" target="#b90">Hohenadl et al., 1995)</ref>, osteopontin <ref type="bibr" target="#b169">(Prince et al., 1991;</ref><ref type="bibr" target="#b190">Sorensen et al., 1994)</ref>, collagens <ref type="bibr" target="#b149">(Mosher, 1984;</ref><ref type="bibr" target="#b28">Bowness et al., 1987;</ref><ref type="bibr" target="#b114">Kleman et al., 1995;</ref><ref type="bibr" target="#b170">Raghunath et al., 1996)</ref>, vitronectin <ref type="bibr" target="#b182">(Sane et al., 1988)</ref>, collagen-tailed acetylcholinesterase <ref type="bibr" target="#b86">(Hand et al., 2000)</ref>, elafin <ref type="bibr" target="#b153">(Nara et al., 1994)</ref> and plasminogen activator inhibitor 2 <ref type="bibr" target="#b175">(Ritchie et al., 2000)</ref>. Another TGase substrate of interest, which is inserted into the extracellular matrix is latent transforming growth factor b (LTGF-b) <ref type="bibr" target="#b116">(Kojima et al., 1993;</ref><ref type="bibr" target="#b177">Rosenthal et al., 2000)</ref>. TGF is released from the insoluble LTGF-b and so TGase 2 is important in regulating the availability of this cytokine in the matrix. Thus, TGase 2 is important in the development of the extracellular matrix. Perturbation of its formation has been implicated in a number of pathological conditions including fibrosis and atherosclerosis <ref type="bibr" target="#b2">(Aeschlimann and Thomazy, 2000)</ref>.</p><p>In addition, TGases may contribute to the formation of atherosclerotic plaques by catalyzing the incorporation of lipoprotein(a) [Lp(a)] into these structures. Lp(a) is a subclass of low-density lipoproteins, and increases in Lp(a) are associated with premature atherosclerosis. However, the mechanism of incorporating Lp(a) into the atheromatous plaque is uncertain. Several studies have shown that Lp(a) is a substrate for TGases in vitro and may be cross-linked into insoluble atherosclerotic plaques in vivo <ref type="bibr" target="#b29">(Bowness et al., 1989;</ref><ref type="bibr" target="#b22">Borth et al., 1991;</ref><ref type="bibr" target="#b176">Romanic et al., 1998)</ref>. In addition, TGase activity is elevated in the inner and middle layers of aortas bearing atherosclerotic lesions of cholesterolfed rabbits <ref type="bibr" target="#b211">(Wiebe et al., 1991)</ref>. Thus, TGases may contribute to atherosclerosis by cross-linking Lp(a) into plaques.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.">Alzheimer's disease</head><p>Alzheimer's disease is associated with the selective loss of neurons in the neocortex, hippocampus, and amygdala, resulting in an impaired cognitive ability. This disease is also characterized by the presence of two types of protein aggregates: extracellular neuritic senile plaques, and intraneuronal neurofibrillary tangles. TGases are likely to contribute to the formation of these aggregates. Isoforms of TGase co-localize with the plaques and tangles in the brains of Alzheimer's disease patients <ref type="bibr" target="#b78">(Gilad and Varon, 1985;</ref><ref type="bibr" target="#b141">Miller and Anderton, 1986;</ref><ref type="bibr" target="#b10">Appelt et al., 1996;</ref><ref type="bibr" target="#b101">Johnson et al., 1997;</ref><ref type="bibr" target="#b112">Kim et al., 1999;</ref><ref type="bibr" target="#b127">Lesort et al., 1999)</ref> and the number of o(g-glutamyl)lysine linkages in insoluble proteins from Alzheimer's disease brains is 30-50 times greater than the number found in normal brain tissues ( 1/10 000 residues) <ref type="bibr" target="#b112">(Kim et al., 1999)</ref>. In addition, total TGase activity is elevated in the affected areas of Alzheimer's disease brains <ref type="bibr" target="#b112">(Kim et al., 1999;</ref><ref type="bibr" target="#b127">Lesort et al., 1999)</ref>. This increase in activity is presumably due to the elevated expression of TGase 1 and 2 mRNAs and proteins <ref type="bibr" target="#b112">(Kim et al., 1999)</ref>. Histochemical studies using TGase isoform-specific antibodies have further demonstrated increased staining for TGase 1 and 2 in the cerebella and cortexes of Alzheimer's disease in comparison to normal individuals <ref type="bibr" target="#b112">(Kim et al., 1999)</ref>.</p><p>In vitro studies have also shown that the components of plaques and tangles are substrates for TGases. For example, b-amyloid (Ab), which is found in a fibrillular form in plaques, is a substrate for TGases. Moreover, cross-linking of Ab by TGase 2 results in the formation of dimers, trimers, tetramers and other high molecular weight oligomers that resemble proteins isolated from the brains of Alzheimer's disease patients <ref type="bibr" target="#b97">(Ikura et al., 1993;</ref><ref type="bibr" target="#b59">Dudek and Johnson, 1994;</ref><ref type="bibr" target="#b91">Ho et al., 1994)</ref>. The full length Ab peptide contains 2 lysines and 1 glutamine residue. <ref type="bibr" target="#b171">Rasmussen et al. (1994)</ref> demonstrated that all three residues are utilized by TGase 2 in the formation of insoluble polymers. In addition to Ab peptide, another amyloid plaque component known as NAC (non-Ab component of amyloid plaque in Alzheimer's disease), which is derived from a synuclein, is also a good substrate for TGases <ref type="bibr" target="#b100">(Jensen et al., 1995)</ref>. Finally, tau the major component of the paired helical filaments <ref type="bibr" target="#b125">(Lee et al., 1991;</ref><ref type="bibr" target="#b79">Goedert et al., 1992</ref>) that make up neurofibrillary tangles <ref type="bibr" target="#b53">(Delacourte and Defossez, 1986;</ref><ref type="bibr" target="#b117">Kosik et al., 1986</ref>) is also a substrate for TGase 2 <ref type="bibr" target="#b58">(Dudek and Johnson, 1993;</ref><ref type="bibr" target="#b143">Miller and Johnson, 1995;</ref><ref type="bibr" target="#b10">Appelt et al., 1996;</ref><ref type="bibr" target="#b151">Murthy et al., 1998)</ref>. Interestingly, the oligomeric products of the TGase and tau reaction are both filamentous and insoluble <ref type="bibr" target="#b58">(Dudek and Johnson, 1993;</ref><ref type="bibr" target="#b9">Appelt and Balin, 1997)</ref>.</p><p>The above observations constitute a strong argument for the participation of TGases in the formation of plaques and tangles in Alzheimer's disease brain. Thus, if plaques and tangles are important in the development of Alzheimer's disease, then the activation of TGases might be a crucial etiological factor in this disease. However, this hypothesis presumes that plaques and tangles contribute to Alzheimer's disease, a notion that is considered controversial. The hypothesis that amyloid contributes to Alzheimer's disease is founded on the observations that the inheritance of mutated amyloid is associated with early onset Alzheimer's disease <ref type="bibr" target="#b77">(Golde et al., 2000)</ref> and that Ab, in particular aggregated Ab, is neurotoxic in vitro <ref type="bibr" target="#b39">(Chen et al., 1996)</ref>. The contrary hypothesis relies on the observation that the amount of amyloid deposits at time of death does not correlate with cognitive ability of either Alzheimer's disease or Down's syndrome patients <ref type="bibr" target="#b51">(Davis et al., 1999;</ref><ref type="bibr" target="#b147">Morris 1999)</ref>.</p><p>Irrespective of the role of plaques or tangles in Alzheimer's disease, TGases may still play a significant role in Alzheimer's disease by cross-linking proteins other than those mentioned above and by participating in apoptosis. In this context, it is important to note that the 30-50-fold increase in o(g-glutamyl)lysine linkages measured in Alzheimer's disease brains was performed on total insoluble proteins extracted from these brains and includes proteins that may not necessarily belong to plaques and tangles. Two potential TGase substrates that might contribute to Alzheimer's disease are glyceraldehyde 3-phosphate dehydrogenase and the a-ketoglutarate dehydrogenase complex. Both of these proteins are inactivated by TGase 2 in the presence of glutamine donors <ref type="bibr" target="#b44">(Cooper et al., 1997a;</ref><ref type="bibr" target="#b68">Gentile et al., 1998)</ref>. The significance of this observation is that decreases in cerebral metabolism precede the onset of brain atrophy and cognitive impairment at least in part, to a loss of a-ketoglutarate dehydrogenase activity <ref type="bibr" target="#b69">(Gibson et al., 2000)</ref>. Thus, TGases may contribute to Alzheimer's disease by inactivating a-ketoglutarate dehydrogenase and other enzymes involved in energy metabolism such as glyceraldehyde 3-phosphate dehydrogenase. This suggests a role for TGases early and throughout Alzheimer's disease. Furthermore, the conditions that favor TGase activation -inflammation and alterations in cerebral Ca 2 + metabolism -occur in Alzheimer's disease. <ref type="bibr" target="#b132">Lue et al. (1996)</ref> have reported that the loss of synapses and dementia correlates with the presence of complement components, eicosanoids and inflammatory cytokines in cerebral amyloid, and other studies have demonstrated that Ca 2 + i stores are perturbed in Alzheimer's disease patients <ref type="bibr" target="#b163">(Peterson and Goldman, 1986;</ref><ref type="bibr" target="#b98">Ito et al., 1994;</ref><ref type="bibr" target="#b70">Gibson et al., 1996)</ref>. Therefore, TGases could be activated in the formative stages of Alzheimer's disease. The above discussion has centered on the inactivation of glyceraldehyde 3-phosphate dehydrogenase and a-ketoglutarate dehydrogenase by TGases, but there are a number of other important substrates for these enzymes, such as histones and neurotransmitters, whose removal or inactivation by TGases, could contribute to neurodegenerative disease <ref type="bibr" target="#b45">(Cooper et al., 1997b;</ref><ref type="bibr" target="#b99">Jeitner et al., 2001)</ref>. Finally, a number of studies have demonstrated that in Alzheimer's disease, the diseased neurons die of apoptosis <ref type="bibr" target="#b48">(Cotman and Anderson, 1995;</ref><ref type="bibr" target="#b123">Lassmann et al., 1995)</ref>. The activation of TGase 2 in particular has also been associated with the onset of apoptosis <ref type="bibr" target="#b62">(Fesus, 1998;</ref><ref type="bibr" target="#b138">Melino and Piacentini, 1998)</ref> although this association remains equivocal <ref type="bibr" target="#b215">(Zhang et al., 1998c)</ref>.</p><p>The preceding arguments favor the hypothesis that TGases may act throughout the development of Alzheimer's disease. In order to test this hypothesis it will be necessary to test for the activation of TGases in individuals with presymptomatic Alzheimer's disease.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.">Huntington's disease: CAG repeat expansions and transglutaminases</head><p>Huntington's disease is characterized by progressive motor and psychiatric disorders, as well as dementia. The most common manifestation of this disease is chorea: involuntary and non-directed motions that disrupt all normal activities eventually leading to death. The clinical progression of Huntington's disease is accompanied by specific neuronal loss and dysfunction, particularly in the striatum and later in the cerebral cortex <ref type="bibr" target="#b205">(Vonsattel and DiFiglia, 1998</ref>). Huntington's disease is an autosomal dominant disease and the mutated gene, and its product (huntingtin), have been identified (The Huntington's Disease Collaborative Research <ref type="bibr">Group, 1993)</ref>. This protein has a molecular mass of 330 kDa but its function remains unknown. Pathological mutations of the huntingtin gene, involving expansion of CAG repeats, result in stretches of polyglutamines of greater than 39 contiguous glutamine residues (from the normal range of 10-25 or so) <ref type="bibr" target="#b83">(Gusella et al., 1993)</ref>. The age of disease onset correlates inversely with the length of the polyglutamine expansion beyond the normal range <ref type="bibr" target="#b196">(Stine et al., 1993;</ref><ref type="bibr" target="#b30">Brandt et al., 1996)</ref>. In addition, Huntington's disease patients display anticipation, that is, a decrease in the age of disease onset with succeeding generations. Anticipation results from the propensity of DNA replication to further expand the CAG repeats to a pathological length, particularly during paternal transmission. Thus, succeeding generations of Huntington's disease patients often inherit a successively longer CAG expansion in the huntingtin protein and a correspondingly earlier age of onset. Finally, homozygous patients do not show any marked clinical difference from their heterozygous siblings, which is consistent with the dominant transmission of the disease <ref type="bibr" target="#b209">(Wexler et al., 1987)</ref>.</p><p>The evidence for the involvement of TGases in Huntington's disease is based on the demonstration of elevated TGase activity in the affected regions of diseased brains, and studies showing that huntingtin is a substrate for TGase 2. Huntingtin is found in the aggregates that characterize Huntington's disease <ref type="bibr" target="#b55">(DiFiglia et al., 1997;</ref><ref type="bibr" target="#b20">Becher et al., 1998)</ref>. <ref type="bibr" target="#b106">Karpuj et al. (1999)</ref> and <ref type="bibr" target="#b127">Lesort et al. (1999)</ref> have both reported increases in TGase activity in the brains of Huntington's disease patients (see the articles by Steinman and Johnson and their colleagues in this issue for further details). In particular, <ref type="bibr" target="#b106">Karpuj et al. (1999)</ref> showed significant elevation in TGase activity in the cortex and cerebellum of Huntington's disease cases. Moreover, TGase activity was increased in the cortical neural extracts of diseased brains. <ref type="bibr" target="#b127">Lesort et al. (1999)</ref> were able to show increases in total TGase activity and immunoreactivity for TGase 2 in the striata of Huntington's disease patients relative to the activity measured in healthy brains. This is an important observation because the striatum is the tissue principally affected in this disease. <ref type="bibr" target="#b127">Lesort et al. (1999)</ref> also demonstrated that TGase 2 immunoreactivity was elevated in both the medium-sized and large spiny neurons, and was present in the nuclear and cytoplasmic compartments of neurons. Despite these studies, it is not clear which TGase isoform(s) are responsible for increases in activity. <ref type="bibr" target="#b112">Kim et al. (1999)</ref> have shown that the mRNAs for TGase 1, 2 and 3 are present in human brains. Recently, we have shown that mRNAs for TGases 1, 2 and 3 are elevated in Huntington's disease patient brains, which suggests that these isoforms may be responsible for the elevations in TGase activity <ref type="bibr">(Kim et al., unpublished observations)</ref>.</p><p>The pathology of Huntington's disease is clearly linked to the polyglutamine expansion in huntingtin. <ref type="bibr" target="#b80">Green (1993)</ref> hypothesized that the pathological gain of function conferred by the elongated polyglutamine domain may due to an increased propensity of such a domain to act as a TGase substrate. That is, an increase in contiguous glutamine residues beyond a certain length would favor the polymerization of huntingtin by TGases. Huntingtin polymers have been identified in the affected regions of Huntington's disease brains <ref type="bibr">(Di-Figlia et al., 1997;</ref><ref type="bibr" target="#b20">Becher et al., 1998)</ref>. Indeed, polyglutamines are excellent substrates for TGase 2 and their ability to act as TGase 2 substrates improves with increasing polyglutamine length <ref type="bibr" target="#b104">(Kahlem et al., 1996;</ref><ref type="bibr" target="#b68">Gentile et al., 1998;</ref><ref type="bibr" target="#b128">Lesort et al., 2000)</ref>. Moreover, <ref type="bibr" target="#b104">Kahlem et al. (1996)</ref> demonstrated that huntingtin containing a pathological length of polyglutamines was a better substrate for TGase 2-mediated polymerization than huntingtin with a shorter, non-pathological glutamine stretch. <ref type="bibr" target="#b106">Karpuj et al. (1999)</ref> extended these studies by using huntingtin constructs containing polyglutamine domains to show that TGase-mediated polymerization was not only increased as a function of the glutamine length, but also as a function of the extent to which huntingtin was truncated. The latter observation is interesting because amino-terminal fragments of huntingtin are found in the nuclei of Huntington's disease patients <ref type="bibr" target="#b55">(DiFiglia et al., 1997;</ref><ref type="bibr" target="#b20">Becher et al., 1998)</ref>. Further, the expression of exon 1 of the huntingtin gene containing an expanded CAG repeat is all that is required to cause Huntington's disease-like symptoms in a mouse model <ref type="bibr" target="#b134">(Mangiarini et al., 1996)</ref>.</p><p>Increasing the polyglutamine length not only increases the number of residues potentially available for TGase-mediated cross-linking, but also increases the apparent affinity of glutamines as TGase substrates, such that more glutamines per length are cross-linked with the longer polyglutamine stretches. This phe-nomenon was demonstrated by <ref type="bibr" target="#b68">Gentile et al. (1998)</ref> using spermidine and various lengths of polyglutamine as TGase substrates. Thus, the binding of amine donors to glutamine residues in a particular sequence -such a length of polyglutamines in a truncated huntingtin molecule -may increase the affinity of some of the remaining glutamines as carboxamide donors for TGase and thereby stimulate TGase activity. The importance of these observations is that it provides a plausible mechanism for the involvement of TGases in Huntington's disease and the occurrence of disease only when the number of polyglutamines exceeds 38 residues. The mechanism would rely on an increased affinity of TGase-bonded polyglutamine for subsequent TGase-catalyzed polymerization. This increased affinity would be a function of length of the polyglutamines and the surrounding huntingtin sequences, such that the loss on the sequences other than the polyglutamine stretches would alter the TGase substrate behavior of huntingtin.</p><p>In support of the above, protein aggregates are found in the brains of Huntington's disease patients and are thought to be a distinguishing characteristic of the pathology <ref type="bibr" target="#b55">(DiFiglia et al., 1997;</ref><ref type="bibr" target="#b20">Becher et al., 1998)</ref>. Insoluble aggregates containing huntingtin are found in the cytosol and nuclei of patients <ref type="bibr" target="#b55">(DiFiglia et al., 1997)</ref>, transgenic animals <ref type="bibr" target="#b51">(Davis et al., 1999)</ref>, and cellular models of this disease <ref type="bibr" target="#b183">(Saudou et al., 1998;</ref><ref type="bibr" target="#b112">Kim et al., 1999)</ref>. Moreover, reducing the aggregate formation improved cell viability in an in vitro system <ref type="bibr" target="#b207">(Wellington et al., 2000)</ref>. Interestingly, the TGase inhibitor cystamine slowed aggregate formation and increased the survival of transgenic mice bearing mutant huntingtin <ref type="bibr" target="#b107">(Karpuj et al., 2000)</ref> (see <ref type="bibr">Cooper et al. in</ref> this issue, for a discussion of the mechanism by which cystamine inhibits TGase). Nevertheless, as discussed in Section 9, there is some doubt as to whether or not protein aggregates contribute to the pathology of Huntington's disease. For example, the presence of aggregates does not correlate well with the pattern of selective neuronal loss in Huntington's disease <ref type="bibr" target="#b84">(Gutekunst et al., 1999;</ref><ref type="bibr" target="#b118">Kuemmerle et al., 1999)</ref>. In addition, cell death due to mutant huntingtin in cell models was exacerbated when aggregate formation was retarded <ref type="bibr" target="#b183">(Saudou et al., 1998)</ref>. These observations suggest that the formation of huntingtin aggregates may not contribute to neuronal death per se and that these aggregate may have a protective role. However, it is still possible that the generation of other TGase-catalyzed polymers may be toxic in Huntington's disease, in the same manner as described earlier for Alzheimer's disease. Given the <ref type="bibr" target="#b68">Gentile et al. (1998)</ref> observations concerning the enhanced incorporation of polyamines into polyglutamine domains, these toxic polymers may be cross-linked by polyamines.</p><p>One important remaining question concerning the involvement of TGases in Huntington's disease is: does the activation of the enzyme(s) coincide with lesions in the disease? Mutated huntingtin alone does not account for the pathology of Huntington's disease because this protein is expressed throughout the nervous system <ref type="bibr" target="#b205">(Vonsattel and DiFiglia, 1998)</ref>. There is a reasonable correspondence between the TGase activity and lesion sites <ref type="bibr" target="#b106">(Karpuj et al., 1999;</ref><ref type="bibr" target="#b127">Lesort et al., 1999)</ref>, but do the conditions for TGase activation correspond with the disease progression? As discussed earlier, TGase activation is stimulated by elevated intracellular calcium, oxidative stress and the release of proinflammatory cytokines. <ref type="bibr">Beal and others (Albin and Greenamyre, 1992;</ref><ref type="bibr" target="#b17">Beal 1994</ref><ref type="bibr" target="#b18">Beal , 1996) )</ref> have proposed that impaired mitochondrial energy production and consequent free radical damage contributes to Huntington's disease pathology, and many studies support this proposal <ref type="bibr" target="#b72">(Goebel et al., 1978;</ref><ref type="bibr" target="#b136">Martin et al., 1992;</ref><ref type="bibr" target="#b26">Browne et al., 1997;</ref><ref type="bibr" target="#b184">Sawa et al., 1999)</ref>. Some of the more interesting findings have come from the use of a mitochondrial poison 3-nitropropionic acid (3-NP), which irreversibly inhibits succinate dehydrogenase. Chronic administration of 3-NP to animals results in lesions and biochemical changes that are characteristic of Huntington's disease <ref type="bibr" target="#b25">(Brouillet et al., 1992;</ref><ref type="bibr" target="#b19">Beal et al., 1993;</ref><ref type="bibr" target="#b24">Brouillet and Hantraye, 1995)</ref>. <ref type="bibr" target="#b128">Lesort et al. (2000)</ref> have further shown that 3-NP increases the in situ TGase activity of cells overexpressing TGase and that this increase in TGase could be attenuated with thiol antioxidants. These data suggest that mitochondrial-derived free radicals could stimulate TGase activity in the course of Huntington's disease. However, the free radicals may not be working directly to stimulate TGase activity. For example, as noted above, hydrogen peroxide and possibly other radical species mobilize intracellular calcium stores <ref type="bibr">(Gibson et al., personal communication)</ref>. In addition, protein oxidation and denaturation may increase the ability of the affected protein to act as a TGase substrate <ref type="bibr" target="#b81">(Groenen et al., 1993)</ref>. Thus, damage to mitochondria during Huntington's disease may result in the production of free radicals from this organelle and the subsequent activation of TGases. How the mitochondria are damaged and how this relates to expression of mutant huntingtin remains to be elucidated.</p><p>Another potential source of oxidative stress could be the release of proinflammatory cytokines from glia surrounding the sensitive neurons. As noted earlier, the activity of TGase 2 is stimulated by TNF-a and INF-g <ref type="bibr">(Kim et al., 2001)</ref>. Unfortunately, the role of inflammation in Huntington's disease has received little attention. Nonetheless, there is evidence of immune dysfunction in this disease. Peripheral lymphocytes from Huntington's disease patients produce greater amounts of IL-2 and INF-g in response to mitogenic stimulation than do healthy controls <ref type="bibr" target="#b126">(Leonardi et al., 1986)</ref>. In addition, these patients have greater circulat-ing levels of the soluble receptors for IL-2 and TNF-a <ref type="bibr" target="#b124">(Leblhuber et al., 1998;</ref><ref type="bibr" target="#b210">Widner et al., 1999)</ref>. However, the release of cytokines from microglia and astrocytes of Huntington's disease patients has not been investigated, and would be a pertinent target of future studies. Finally, the expression of huntingtin may influence cytokine release. <ref type="bibr" target="#b139">Metzler et al. (2000)</ref> have shown that huntingtin is required for the generation and expansion of hemopoietic cells. The differentiation and proliferation of these cells is tightly regulated by cytokines and suggests that huntingtin may modulate cytokine release. Thus, mutant huntingtin may stimulate cytokine release, which in turn activates TGases.</p><p>In addition to Huntington's disease, there are seven other neurodegenerative diseases which feature CAG trinucleotide repeat expansions: spinobulbar muscular atrophy (Kennedy disease) (La <ref type="bibr" target="#b121">Spada et al., 1991)</ref>, spinocerebellar ataxia type 1 (SCA1) <ref type="bibr" target="#b159">(Orr et al., 1993)</ref>, SCA2 <ref type="bibr" target="#b168">(Pulst et al., 1996)</ref>, SCA6 <ref type="bibr" target="#b218">(Zhuchenko et al., 1997)</ref>, and SCA7 <ref type="bibr" target="#b50">(David et al., 1997)</ref>, SCA3 (Machado -Joseph disease) <ref type="bibr" target="#b195">(Stevanin et al., 1996)</ref>, dantatorubral-pallidoluysian atrophy (Smith disease) <ref type="bibr" target="#b199">(Tanaka et al., 1996)</ref>. All of these diseases are inherited in an autosomal dominant fashion, and are characterized by a progressive impairment of coordination and motor neuron degeneration associated with variable mental syndromes <ref type="bibr" target="#b205">(Vonsattel and DiFiglia, 1998)</ref>. CAG nucleotide repeats are found in the responsible genes for all of these diseases, and initiate pathology when the polyglutamine repeat length is over 35-40 residues in the mutated gene product, except SCA6 (where 21-28 residues is pathological). Finally, a small fraction of schizophrenic patients also bear CAG repeat expansions <ref type="bibr" target="#b204">(Vincent et al., 2000)</ref>. Thus, it is possible that TGases are involved in these diseases in much the same manner that has been suggested for Huntington's disease.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="11.">Parkinson's disease</head><p>Parkinson's disease is the second most common neurodegenerative disorder after Alzheimer's disease and is characterized by tremor, bradykinesia, rigidity and postural instability <ref type="bibr" target="#b174">(Riess et al., 1998)</ref>. These motor disorders result primarily from a loss of dopaminergic neurons of the nigro-striatal pathway. Histologically, Parkinson's disease is characterized by a widespread distribution of Lewy bodies, which are intracytoplasmic aggregates of between 5 and 25 mm in diameter that feature a dense eosinophilic core and pale surrounding halo. Although Lewy bodies are thought to play a causative role in Parkinson's disease, these structures also have been identified in some cases of Alzheimer's disease <ref type="bibr" target="#b140">(Mezey et al., 1998)</ref>.</p><p>The major component of Lewy bodies is a-synuclein <ref type="bibr" target="#b189">(Spillantini et al., 1997</ref>) and a-synuclein mutations have been reported for cases of familial Parkinson's disease <ref type="bibr" target="#b166">(Polymeropoulos et al., 1997;</ref><ref type="bibr" target="#b174">Riess et al., 1998)</ref>. a-Synuclein is a 140 amino acid protein that is homologous to two other gene products, band g-synuclein. However, the functions of these proteins remain largely unknown. Interestingly, a fragment of a-synuclein, known as the non-amyloid component (NAC), has been detected in the Lewy bodies of Parkinson's disease patients <ref type="bibr" target="#b11">(Arima et al., 1998)</ref> and the neuritic plaques of Alzheimer's disease patients <ref type="bibr" target="#b212">(Wirths et al., 2000)</ref>. NAC is particularly interesting because it acts as a substrate for TGases <ref type="bibr" target="#b100">(Jensen et al., 1995)</ref>, and is neurotoxic to primary dopaminergic neurons <ref type="bibr" target="#b66">(Forloni et al., 2000)</ref>, as well as to neuroblastoma cells <ref type="bibr" target="#b61">(El-Agnaf et al., 1998)</ref>. TGases catalyze the formation of NAC polymers and aggregates of NAC and b-amyloid peptides. NAC contains glutamine and lysine residues that act as carboxamide and amine donors, respectively, for TGasemediated o(g-glutamyl)lysine formation, and so allow the formation of NAC polymers. The formation of NAC polymers is important because the aggregated molecule is more toxic than the monomeric form <ref type="bibr" target="#b61">(El-Agnaf et al., 1998;</ref><ref type="bibr" target="#b66">Forloni et al., 2000)</ref>. Thus, TGases may contribute to the pathology of Parkinson's and Alzheimer's diseases by catalyzing the formation of toxic NAC aggregates.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="12.">Progressive supranuclear palsy</head><p>Progressive supranuclear palsy is a motor disorder that initially presents in patients having unexpected falls. The later manifestations of the disease present as postural instability, vertical gaze palsy, axial rigidity, dysarthria and dementia. The most common pathological findings in this disease are midbrain atrophy with dilation of the aqueduct of Sylvius and depigmentation of the substantia nigra. These features are associated with the loss of neurons in the substantia nigra, globus pallidus, subthalamic nucleus, basal ganglia, diencephalon and brain stem <ref type="bibr" target="#b76">(Golbe et al., 1989;</ref><ref type="bibr" target="#b74">Golbe, 1993)</ref>. Currently, the frequency of progressive palsy is approximately 1-2 per 100 000 <ref type="bibr" target="#b75">(Golbe et al., 1988)</ref>.</p><p>Neurofibrillary tangles occur in the affected areas of progressive supranuclear palsy patients <ref type="bibr" target="#b74">(Golbe, 1993)</ref>. Similar structures are found in Alzheimer's disease and suggestions that TGases may be responsible for the formation of neurofibrillary tangles in progressive supranuclear palsy have been made based on the following observations. TGase activity is elevated in Alzheimer's diseased brains, and tau -the major component of the tangles -is a TGase substrate (see Section 9). Tau has also been identified as a major component of the detergent-insoluble proteins isolated from the brains of progressive supranuclear palsy patients <ref type="bibr" target="#b64">(Flament et al., 1991)</ref>. These tau aggregates also contain o(g-glutamyl)lysine cross links <ref type="bibr" target="#b216">(Zemaitaitis et al., 2000a)</ref>. Moreover, the number of o(g-glutamyl)lysine cross-links is significantly greater in the globus pallidus and pons regions of progressive supranuclear palsy patients than in controls. Co-localization studies further showed that the o(g-glutamyl)lysine cross-links and aggregated tau were coincident <ref type="bibr" target="#b216">(Zemaitaitis et al., 2000a)</ref>. Recently, the same group was able to show that the messages for TGases 1 and 2 are elevated in both the cerebellum and globus pallidus of patients <ref type="bibr" target="#b217">(Zemaitaitis et al., 2000b)</ref>. The authors also showed that the mRNAs for TGases 1 and 2 are elevated in both the cerebellum and globus pallidus of progressive supranuclear palsy patients <ref type="bibr" target="#b217">(Zemaitaitis et al., 2000b)</ref>. In particular, TGase 1 mRNA was highly increased in the cerebellum.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="13.">Concluding comments</head><p>Our aim in reviewing the role of TGases in disease has been to discern both the general and specific roles that this family of enzymes play in pathology. It is clear that TGases have specific roles in the etiology of the diseases discussed above. Genetic mutations in TGase 1 specifically affect skin barrier function in lamella ichthyosis and X-linked ichthyosis, and factor XIIIa mutations produce bleeding disorders. The inappropriate presentation of TGases and substrates/cross-linked aggregates to the immune system contribute to the autoimmune aspects of celiac and other diseases. Although the activation of TGases appears to be a uniform response in the neurological diseases discussed above, it appears to be restricted to the disease-affected areas. One of the more generalized aspects of TGase activation in the neurological diseases is the contribution of cross linking to the formation of proteinaceous aggregates. Nevertheless, there is some specificity in the composition of the aggregates in these disease states. Tau is a major component of the tangles in Alzheimer's disease whereas huntingtin is the primary constituent of the aggregates in Huntington's disease. Naturally, there is some overlap with respects to the aggregate composition in these diseases. Tau polymers are found in both Alzheimer's disease and progressive supranuclear palsy. However, this may reflect heterogeneity in the pathology of these diseases rather than a lack of specificity in the involvement of TGases.</p><p>The following factors determine the extent to which TGases specifically may contribute to a disease: availability of potentially toxic substrates, the mechanism of enzyme activation, and which TGase isoform(s) are activated. The type of substrates that are available for cross-linking will be determined by cell type. Conse-quently, aggregates of crystallin, tau and huntingtin form in cataract, Alzheimer's and Huntington's disease, respectively, because these are the proteins produced by the injured cells. The fact that aggregates form, reflects both the function of the enzyme -polypeptide crosslinking-and the inability of the diseased cells to remove these aggregates. What is not known is whether the various aggregates contribute to the toxicity. Obviously, aggregated crystallin accounts for the opacification in cataract. However, in vitro experiments suggest that polymerized huntingtin may not be neurotoxic. To what extent do these polymers represent the aggregates that form in vivo? The aggregates that form in the course of disease are likely to be composed of other TGase substrates, some of which may be toxic either by their inclusion into the aggregate or their removal from the cellular milieu. Thus, it will be necessary to identify all of the components of the aggregates in order to assess how they participate in pathology.</p><p>Proteins may also become better substrates as a result of the disease process. For example, oxidative stress is an important component of cataract formation and Alzheimer's disease. It may be possible that the oxidation of crystallin and tau result in their denaturation and thereby increase their capacity for TGase-catalyzed cross linking.</p><p>Clearly, substrate availability alone cannot account for disease specificity. Tau and huntingtin are expressed in both normal and diseased tissues. Similarly, numerous cells along the alimentary track are exposed to gliadin, but the damage in celiac disease is restricted to the upper small intestine. Thus, other factors must contribute to the etiology of disease and to the activation of TGases, in particular, inflammation, oxidative stress and elevations in intracellular calcium. Of these factors, inflammation is especially interesting because in this process TGases can be activated by a number of mechanisms including the release of proinflammatory cytokines and reactive oxygen species. Understanding the means by which TGases are specifically activated in disease will greatly aid in elucidating the role of these enzymes in the disease process.</p><p>One of the more interesting observations is that the expression of TGase isoform mRNAs varies among the various diseases, which suggests a certain specificity for the involvement of these enzymes. The mRNAs for TGase 1 and 2 are elevated in inclusion body myositis <ref type="bibr" target="#b41">(Choi et al., 2000)</ref>, progressive supranuclear palsy <ref type="bibr" target="#b217">(Zemaitaitis et al., 2000b</ref>), Alzheimer's <ref type="bibr" target="#b112">(Kim et al., 1999)</ref> and Huntington's disease <ref type="bibr">(Kim, Jeitner, Cooper, Blass and Steinert, unpublished observations)</ref>. TGase 3 message is also elevated in Huntington's disease. Moreover, there is significant variation in the extent to which the isoforms are expressed. Unfortunately, it is not yet known if the mRNAs are being translated into active enzymes. It is important to determine which TGase isoforms are activated in disease because the substrates of these isoforms may include proteins and polyamines critical in the disease process. Elucidation of the role that each TGase isoform performs in disease promises to yield new strategies for treating of these pathologies. In the cases of genetic diseases of TGase 1 and factor XIIIa, gene therapy remains an elusive but necessarily desirable goal. Treatment for those degenerative diseases that result in over expression or aberrant expression of one TGase isoform or another remains an even more difficult challenge. Nevertheless, one plausible approach might be to inhibit the TGase expression by use of isoform-specific inhibitors. While generic TGase inhibitors do exist (e.g. thiol-reactive reagents), they are non-specific and even highly toxic. Therefore, it seems reasonable to these authors that some effort should be devoted to the development of safer and more specific inhibitors. The simple rationale is that diminution of the aberrant TGase activity(ies) might halt the progression of the tissue degeneration and thereby ameliorate the disease symptoms.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>Autoantibodies against TGase substrates in autoimmune disease</figDesc><table><row><cell>TGase</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>The authors would like to acknowledge Drs A.J.L. Cooper, L. DiGiorio and G. Gibson for their insightful comments on some of the topics covered in this review. T.M.J. was supported by PO1 AG1930 during the preparation of this review.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Characterization of autoantibody in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematous patients</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Z</forename><surname>Adyel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hentati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boulila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hachicha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ternynck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Avrameas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Adyadi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Lab. Anal</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="451" to="457" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Tansglutaminases: protein cross-linking enzymes in body fluids</title>
		<author>
			<persName><forename type="first">D</forename><surname>Aeschlimann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paulsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thromb. Haemost</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="402" to="415" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Protein crosslinking in assembly and remodeling of extracellular matrices: the role of transglutaminases</title>
		<author>
			<persName><forename type="first">D</forename><surname>Aeschlimann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Thomazy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Connect. Tissue Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1" to="27" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Transglutaminasecatalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate</title>
		<author>
			<persName><forename type="first">D</forename><surname>Aeschlimann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kaupp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paulsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell. Biol</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="881" to="892" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Alternative excitotoxic hypotheses</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Albin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Greenamyre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="733" to="738" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Calcium-dependent proteolysis in rabbit lens epithelium after oxidative stress</title>
		<author>
			<persName><forename type="first">M</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sjostrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Karlsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ophthalmic Res</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="157" to="167" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Calpain activates two transglutaminases from porcine skin</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Immamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Murachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kannagi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Dermatol. Res</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="380" to="384" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Calciuminduced intracellular cross-linking of lipocortin I by tissue transglutaminase in A431 cells. Augmentation by membrane phospholipids</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Imamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Owada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kannagi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">266</biblScope>
			<biblScope unit="page" from="1101" to="1108" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase</title>
		<author>
			<persName><forename type="first">H</forename><surname>Arentz-Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Korner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Molberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Quarsten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Vader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Kooy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Lundin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roepstorff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sollid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Mcadam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="603" to="612" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Appelt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Balin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">745</biblScope>
			<biblScope unit="page" from="21" to="31" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Localization of transglutaminase in hippocampal neurons: implications for Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Appelt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Kopen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Boyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Balin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Histochem. Cytochem</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1421" to="1427" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Immunoelectron-microscopic demonstration of NACP/a-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson&apos;s disease and in dementia with Lewy bodies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sunohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hirai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Izumiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tonozuka-Uehara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kawai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">808</biblScope>
			<biblScope unit="page" from="93" to="100" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Amyloid precursor epitopes in muscle fibers of inclusion body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="551" to="560" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Insulin-dependent diabetes mellitus as an autoimmune disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Bach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr. Rev</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="516" to="542" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Congenital recessive ichthyosis unlinked to loci for epidermal transglutaminases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Bale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Compton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Digiovanna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="808" to="811" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Core histones are glutaminyl substrates for tissue transglutaminase</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ballestar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Abad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Franco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="18817" to="18824" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease associated transglutaminase autoantibodies</title>
		<author>
			<persName><forename type="first">F</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Babu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Hoffenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rewers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Eisenbarth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Autoimmun</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="143" to="148" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Huntington&apos;s disease, energy, and excitotoxicity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Beal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Aging</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="275" to="276" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Mitochondria, free radicals, and neurodegeneration</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Beal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="661" to="666" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Beal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Brouillet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ferrante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Kowall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Storey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Srivastava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hyman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="4181" to="4189" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Intranuclear neuronal inclusions in Huntington&apos;s disease and DRPLA</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Becher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kotzuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Bates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="387" to="397" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Transglutaminase-catalyzed polymerization of troponin in vitro</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bergamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Signorini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barbato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Menabo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Di Lisa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gorza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beninati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="page" from="201" to="206" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase</title>
		<author>
			<persName><forename type="first">W</forename><surname>Borth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Harpel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">266</biblScope>
			<biblScope unit="page" from="18149" to="18153" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Protein oxidation and lens opacity in humans</title>
		<author>
			<persName><forename type="first">F</forename><surname>Boscia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Grattagliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vendemiale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Micelli-Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Altomare</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Invest. Ophthalmol. Vis. Sci</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="2461" to="2465" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates</title>
		<author>
			<persName><forename type="first">E</forename><surname>Brouillet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hantraye</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Neurol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="469" to="473" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates</title>
		<author>
			<persName><forename type="first">E</forename><surname>Brouillet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hantraye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ferrante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dolan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leroy-Willig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Kowall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Beal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="7105" to="7109" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Oxidative damage and metabolic dysfunction in Huntington&apos;s disease: selective vulnerability of the basal ganglia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Browne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Bowling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Macgarvey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Baik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Muqit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Bird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Beal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="646" to="653" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The Goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Borza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">O</forename><surname>Netzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leinonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Todd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cervera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Saus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Hudson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="6030" to="6037" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bowness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Folk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Timpl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">262</biblScope>
			<biblScope unit="page" from="1022" to="1024" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Transglutaminasecatalysed cross-linking: a potential mechanism for the interaction of fibrinogen, low density lipoprotein and arterial type III procollagen</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bowness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Tarr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I</forename><surname>Wiebe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thromb. Res</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="357" to="367" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Trinucleotide repeat length and clinical progression in Huntington&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Brandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Bylsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">C</forename><surname>Stine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ranen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="527" to="531" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bruce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Bjarnason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Peters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Sci</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="S73" to="S79" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Keratin cross-linking and epidermal transglutaminase. A review with observations on the histochemical and immunochemical localization of the enzyme</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Buxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Wuepper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="107" to="112" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing</title>
		<author>
			<persName><forename type="first">E</forename><surname>Candi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Melino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lahm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ceci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">G</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ciani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="page" from="13693" to="13702" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Evidence for an antigen-driven selection process in human autoantibodies against acetylcholine receptor</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cardona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Pritsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dumas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Bach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dighiero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Immunol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1215" to="1223" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Inclusion body myositis, a review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1105" to="1114" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Coeliac disease in the year 2000: exploring the iceberg</title>
		<author>
			<persName><forename type="first">C</forename><surname>Catassi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Ratsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fabiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rossini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bordicchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Candela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Coppa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Giorgi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page" from="200" to="203" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Transient formation of superoxide radicals in polyunsaturated fatty acid-induced brain swelling</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Fishman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1004" to="1007" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Cross-linking sites in human and bovine fibrin</title>
		<author>
			<persName><forename type="first">R</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Doolittle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="4487" to="4491" />
			<date type="published" when="1971">1971</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">The neurochemical and behavioral effects of b-amyloid peptide</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Barnes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">720</biblScope>
			<biblScope unit="page" from="54" to="60" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood</title>
		<author>
			<persName><forename type="first">I</forename><surname>Chimanovitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Georgi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kroiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Stolz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Apitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Brocker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zillikens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Dermatol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="527" to="532" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Sunwoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="8703" to="8710" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?</title>
		<author>
			<persName><forename type="first">O</forename><surname>Chosidow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Doppler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bensimon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Joly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Salachas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lacomblez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Prost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Camu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Frances</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Herson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Meininger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Dermatol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="521" to="524" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Mutation causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast</title>
		<author>
			<persName><forename type="first">M</forename><surname>Coggan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miloszewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Woodfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Board</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="2455" to="2460" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases?</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J L</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Sheu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Onodera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Blass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="431" to="434" />
			<date type="published" when="1997">1997a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J L</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Sheu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Onodera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Blass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="12604" to="12609" />
			<date type="published" when="1997">1997b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Transglutaminase-catalyzed incorporation of polyamines into phospholipase A2</title>
		<author>
			<persName><forename type="first">E</forename><surname>Cordella-Miele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Miele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beninati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Mukherjee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biochem</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="164" to="173" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values</title>
		<author>
			<persName><forename type="first">G</forename><surname>Corrao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Corazza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Andreani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Torchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Valentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Galatola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Quaglino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gasbarrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Di Orio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="771" to="775" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">A potential role for apoptosis in neurodegeneration and Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Cotman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="19" to="45" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Amino acid sequence studies on the alpha chain of human fibrinogen. Exact location of cross-linking acceptor sites</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Cottrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Watt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Doolittle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="5405" to="5410" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion</title>
		<author>
			<persName><forename type="first">G</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stevanin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Durr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yvert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cancel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Imbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Saudou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Drabkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gemmill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Giunti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Benomar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Agid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Mandel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brice</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="65" to="70" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Alzheimer neuropathologic alterations in aged cognitively normal subjects</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Wekstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Markesbery</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="376" to="388" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Gene disruption of tissue transglutaminase</title>
		<author>
			<persName><forename type="first">V</forename><surname>De Laurenzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Melino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Biol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="148" to="155" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Alzheimer&apos;s disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments</title>
		<author>
			<persName><forename type="first">A</forename><surname>Delacourte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Defossez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurol. Sci</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="173" to="186" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Human collagen II peptide 256 -271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Diab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>L'faqihi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Loubet-Lescoulie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>De Preval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Coppin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="36" to="44" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Difiglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meloni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-P</forename><surname>Vonsattel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Reeves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Carraway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Boyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Arronin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="1990" to="1993" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Identification of tissue transglutaminase as the autoantigen of celiac disease</title>
		<author>
			<persName><forename type="first">W</forename><surname>Dieterich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ehnis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Donner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Volta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Riecken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schuppan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="797" to="801" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis</title>
		<author>
			<persName><forename type="first">W</forename><surname>Dieterich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Laag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bruckner-Tuderman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Reunala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zagoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Riecken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schuppan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="133" to="136" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Dudek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1159" to="1162" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Dudek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">651</biblScope>
			<biblScope unit="page" from="129" to="133" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Transglutaminase-induced cross-linking between subdomain 2 of G-actin and the 636-642 lysine-rich loop of myosin subfragment 1</title>
		<author>
			<persName><forename type="first">L</forename><surname>Eligula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Motoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Seguro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Muhlrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biophys. J</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="953" to="963" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>El-Agnaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Curran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Middleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ingenito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pessi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Neill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wallace</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS. Lett</title>
		<imprint>
			<biblScope unit="volume">440</biblScope>
			<biblScope unit="page" from="71" to="75" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Fesus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell. Mol. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="683" to="694" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Two new loci for autosomal recessive ichthyosis on chromosomes 3p21 and 19p12-q12 and evidence for further genetic heterogeneity</title>
		<author>
			<persName><forename type="first">J</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Faure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bouadjar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Blanchet-Bardon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Karaduman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Emre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ozguc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weissenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Prud'homme</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="904" to="913" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Abnormal tau proteins in progressive supranuclear palsy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Flament</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Delacourte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Verny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Hauw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Javoy-Agid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta. Neuropathol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="591" to="596" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">The o-(g-glutamyl)lysine cross-link and the catalytic role of transglutaminases</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Folk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Finlayson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv. Protein Chem</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1" to="133" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Alpha-synuclein and Parkinson&apos;s disease: selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo</title>
		<author>
			<persName><forename type="first">G</forename><surname>Forloni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Bertani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Calella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Thaler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Invernizzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="632" to="640" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss</title>
		<author>
			<persName><forename type="first">K</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ogawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Nagata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurol. Sci</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="53" to="57" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases</title>
		<author>
			<persName><forename type="first">V</forename><surname>Gentile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Calvani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Melone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cotrufo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J L</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Blass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Peluso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Biochem. Biophys</title>
		<imprint>
			<biblScope unit="volume">352</biblScope>
			<biblScope unit="page" from="314" to="321" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">The a-ketoglutarate dehydrogenase complex in neurodegeneration</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Sheu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Blass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">Y</forename><surname>Calingasan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurochem. Int</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="97" to="112" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Calcium stores in cultured fibroblasts and their changes with Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Toral-Barza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Szolosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tofel-Grehl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1316</biblScope>
			<biblScope unit="page" from="71" to="77" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<monogr>
		<title level="m" type="main">Oxidative stress produces Alzheimer&apos;s Disease-like modifications in calcium homeostasis and mitochondrial enzymes in cultured fibroblasts</title>
		<author>
			<persName><forename type="first">G</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Jeitner</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>submitted</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Goebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Heipertz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Scholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Iqbal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Tellez-Nagel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="23" to="31" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Ghohestani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Hudson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Claudy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Uitto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="16002" to="16006" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Progressive supranuclear palsy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Golbe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Parkinsonian Syndromes. Marcel Dekker</title>
				<editor>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Stern</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Koller</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1993">1993</date>
			<biblScope unit="page" from="227" to="247" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Prevalence and natural history of progressive supranuclear palsy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Golbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Schoenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Duvoisin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1031" to="1034" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Prevalence and natural history of progressive supranuclear palsy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Golbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Schoenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Duvoisin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1031" to="1034" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Golde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Eckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Younkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1502</biblScope>
			<biblScope unit="page" from="172" to="187" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Transglutaminase activity in rat brain: characterization, distribution, and changes with age</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Gilad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Varon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1522" to="1526" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms</title>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Spillantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Cairns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Crowther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="159" to="168" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism</title>
		<author>
			<persName><forename type="first">H</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="955" to="956" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Exposure of beta H-crystallin to hydroxyl radicals enhances the transglutaminasesusceptibility of its existing amine-donor and amine-acceptor sites</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Groenen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seccia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Smulders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gravela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Cheeseman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bloemendal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>De Jong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">295</biblScope>
			<biblScope unit="page" from="399" to="404" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Thrombin cleavage-independent deposition of fibrinogen in extracellular matrices</title>
		<author>
			<persName><forename type="first">G</forename><surname>Guadiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Sporn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Simpson-Haidaris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="2644" to="2653" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Molecular genetics of Huntington&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Gusella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Ambrose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Duyao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Neurol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1157" to="1163" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Nuclear and neuropil aggregates in Huntington&apos;s disease: relationship to neuropathology</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Gutekunst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Mulroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kuemmerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ferrante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Hersch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="2522" to="2534" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<monogr>
		<author>
			<persName><forename type="first">B</forename><surname>Halliwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M C</forename><surname>Gutteridge</surname></persName>
		</author>
		<title level="m">Free Radicals in Disease and Medicine</title>
				<meeting><address><addrLine>Oxford</addrLine></address></meeting>
		<imprint>
			<publisher>Clarendon Press</publisher>
			<date type="published" when="1989">1989</date>
			<biblScope unit="page" from="289" to="296" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Stabilization of collagentailed acetylcholinesterase in muscle cells through extracellular anchorage by transglutaminase-catalyzed cross-linking</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Haynes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Biochem</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="65" to="76" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with or without insulin-dependent diabetes mellitus</title>
		<author>
			<persName><forename type="first">S</forename><surname>Haralambous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Blackwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Mappouras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Weir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kemmett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lymberi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autoimmunity</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="267" to="275" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Two genetic defects in a patient with complete deficiency of the a-subunit for coagulation factor XIII</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hashiguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Morishita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ichinose</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="145" to="150" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Natural autoantibodies are involved in the haemolytic anaemia of NZB mice</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hentati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Payelle-Brogard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jouanne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Avrameas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ternynck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Autoimmunity</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="425" to="439" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminase C-catalyzed modification</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hohenadl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Timpl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paulsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aeschlimann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">270</biblScope>
			<biblScope unit="page" from="23415" to="23420" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Cross-linking of beta-amyloid protein precursor catalyzed by tissue transglutaminase</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Gregory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Smirnova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Zoubine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Festo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="page" from="151" to="154" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Ca 2 + -dependent inactivation of acetylcholine receptors by an endogenous transglutaminase</title>
		<author>
			<persName><forename type="first">F</forename><surname>Hucho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bandini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="page" from="279" to="282" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Mutations of keratinocyte transglutaminase in lamellar ichthyosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rettler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bernasconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Lavrijsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ponec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lautenschlager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Schorderet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hohl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="page" from="525" to="528" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Amino acid sequence of a subunit of human factor XIII</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ichinose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Hendrickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fujikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Davie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="6900" to="6906" />
			<date type="published" when="1986">1986a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Amino acid sequence of the b subunit of human factor XIIIa, a protein composed of ten repetitive segments</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ichinose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Mcmullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fujikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Davie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="4633" to="4638" />
			<date type="published" when="1986">1986b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">The presence of autoantibody to lipocortin-I in autoimmune-prone MRL mice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ikai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kanauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Furukawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Immamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autoimmunity</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="239" to="240" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Cross-linking of a synthetic partial-length (1 928) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ikura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sasaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">326</biblScope>
			<biblScope unit="page" from="109" to="111" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Internal Ca 2 + mobilization is altered in fibroblasts from patients with Alzheimer disease</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Oka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Etcheberrigaray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Mcphie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tofel-Grehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Alkon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="534" to="538" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">A sensitive fluorescent assay for tissue transglutaminase</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Jeitner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-L</forename><surname>Fuchsbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Blass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J L</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal. Biochem</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="198" to="206" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Sorensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gliemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Rasmussen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="91" to="94" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Transglutaminase activity is increased in Alzheimer&apos;s disease brain</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Lockhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Zinnerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Powers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">751</biblScope>
			<biblScope unit="page" from="323" to="329" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Johansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Gjertsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vartdal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Buus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Thorsby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Lundin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sollid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Immunol. Immunopathol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="288" to="293" />
			<date type="published" when="1996">1996a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Identification of a putative motif for binding of peptides to HLA-DQ2</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Johansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vartdal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Eriksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Thorsby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sollid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="177" to="182" />
			<date type="published" when="1996">1996b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kahlem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Terre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Djian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl. Acad. Sci</title>
				<meeting>Natl. Acad. Sci<address><addrLine>USA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1996">1996</date>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="14580" to="14585" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Primary structure of microbial transglutaminase from Strepto6erticillium sp. strain s-8112</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kanaji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ozaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawajiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Motoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimonishi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">268</biblScope>
			<biblScope unit="page" from="11565" to="11572" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington&apos;s disease brain nuclei</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Karpuj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Garren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Slunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gusella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Becher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Steinman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl. Acad. Sci. USA 96</title>
				<meeting>Natl. Acad. Sci. USA 96</meeting>
		<imprint>
			<date type="published" when="1999">1999</date>
			<biblScope unit="page" from="7388" to="7393" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Cystamine, a competitor for transglutaminase, slows the progression of Huntington&apos;s disease in a transgenic mouse model without altering the formation of nuclear inclusions</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Karpuj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Becher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Steinman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Soc. Neurosci. Abstr</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="480" to="485" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bae</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp. Mol. Med</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="257" to="262" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<monogr>
		<title level="m" type="main">Interferon-g induces transglutaminase 2 expression in rat small intestinal cells: implications for the pathogenesis of celiac disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>submitted</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">The structure of the transglutaminase 1 enzyme Deletion cloning reveals domains that regulate its specific activity and substrate specificity</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">G</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="27979" to="27986" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Expression of transglutaminase 1 in human epidermis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoneda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="211" to="217" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in AD</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Pant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="30715" to="30721" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<monogr>
		<title level="m" type="main">IFN-g and TNF-a induce the expression of TGase 2 in the cultured myoblast cell system</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>submitted</note>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Kleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aeschlimann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paulsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Der Rest</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="13768" to="13775" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Koffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Simonis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stroncek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="139" to="142" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Requirement for transglutaminase in the activation of latent transforming growth factorbeta in bovine endothelial cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Rifkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell. Biol</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="439" to="448" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Microtubule-associated protein t (tau) is a major antigenic component of paired helical filaments in Alzheimer disease</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Kosik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Joachim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="4044" to="4048" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Huntington aggregates may not predict neuronal death in Huntington&apos;s disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kuemmerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Gutekunst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Beal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Hersch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ferrante</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="842" to="849" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Human alpha-lactalbumin and bovine beta-lactoglobulin absorption in infants</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kuitunen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Savilahti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sarnesto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="354" to="360" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">HLA-DQB1 codon 57 is critical for peptide binding and recognition</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Kwok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Domeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Nepom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Koelle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="1253" to="1258" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Androgen receptor gene mutations in Xlinked spinal and bulbar muscular atrophy</title>
		<author>
			<persName><forename type="first">La</forename><surname>Spada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Lubahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Harding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Fischbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">352</biblScope>
			<biblScope unit="page" from="77" to="79" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Antibodies to tissue TGase C in type I diabetes</title>
		<author>
			<persName><forename type="first">V</forename><surname>Lampasona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bonfanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bazzigaluppi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Venerando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chiumello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bonifacio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1195" to="1198" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<monogr>
		<title level="m" type="main">Cell death in Alzheimer&apos;s disease evaluated by DNA fragmentation in situ</title>
		<author>
			<persName><forename type="first">H</forename><surname>Lassmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bancher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Breitschopf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wegiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bobinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Wisniewski</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1995">1995</date>
			<publisher>Acta Neuropath</publisher>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="35" to="41" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Activated immune system in patients with Huntington&apos;s disease</title>
		<author>
			<persName><forename type="first">F</forename><surname>Leblhuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Walli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Tilz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Widner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Laccone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fuchs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Chem. Lab. Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="747" to="750" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">A68: a major subunit of paired helical filaments and derivatized forms of normal Tau</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Balin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Otvos</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Trojanowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">251</biblScope>
			<biblScope unit="page" from="675" to="678" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Evidence of T-lymphocyte functional impairment in Huntington&apos;s disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Leonardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Caria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Arata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Di Geronimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Canonica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fudenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Immunol. Immunopathol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="121" to="130" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Tissue transglutaminase is increased in Huntington&apos;s disease brain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lesort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ferrante</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<date type="published" when="1999">1999. 2018 -2027</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Impaired mitochondrial function results in increased tissue transglutaminase activity in situ</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lesort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tucholski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="1951" to="1961" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Formation of a 55,000-weight cross-linked b-crystallin dimer in the calcium treated lens. A model for cataract</title>
		<author>
			<persName><forename type="first">L</forename><surname>Lorand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Velasco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1525" to="1531" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Novel inhibitors against the transglutaminase-catalyzed cross-linking of lens proteins</title>
		<author>
			<persName><forename type="first">L</forename><surname>Lorand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Stern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Velasco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp. Eye Res</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="531" to="536" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Leff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Targoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicine (Baltimore)</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="360" to="674" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Inflammation, Ab deposition, and neurofibrillary tangle formation as correlates of Alzheimer&apos;s disease neurodegeneration</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Lue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Brachova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Civin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rogers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropath. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1083" to="1088" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak control</title>
		<author>
			<persName><forename type="first">I</forename><surname>Lungderg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brengman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="9" to="16" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice</title>
		<author>
			<persName><forename type="first">L</forename><surname>Mangiarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sathasivam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cozens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Harper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hetherington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lawton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Trottier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lehrach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Bates</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="493" to="506" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (&apos;celiac sprue&apos;)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Marsh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="330" to="354" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ammann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Stoessl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Shtybel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hayden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Cortical glucose metabolism in Huntington&apos;s disease</title>
				<imprint>
			<date type="published" when="1992">1992</date>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="223" to="229" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">Amyloid plaque core protein in Alzheimer disease and Down syndrome</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Masters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Simms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Weinman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Multhaup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyreuther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="4245" to="4249" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Tissue&apos; transglutaminase in cell death: a downstream or a multifunctional upstream effector?</title>
		<author>
			<persName><forename type="first">G</forename><surname>Melino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piacentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">430</biblScope>
			<biblScope unit="page" from="59" to="63" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Huntingtin is required for normal hematopoiesis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Metzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Helgason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dragatsis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pineault</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Zeitlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Humphries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hayden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Mol. Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="387" to="394" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Alpha synuclein in neurodegenerative disorders: murderer or accomplice?</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mezey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dehejia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Harta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Papp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Polymeropoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Brownstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="755" to="757" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Transglutaminase and the neuronal cytoskeleton in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Anderton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1912" to="1922" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Barbieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Balow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Exp. Immunol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="373" to="379" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Transglutaminase cross-linking of the tau protein</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1760" to="1770" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">A role for tissue transglutaminase in hepatic injury and fibrogenesis and its regulation by NF-kappaB</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mirza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frizell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Maddukuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schwarting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Norton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Zern</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="page" from="G281" to="G288" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">HLA restriction patterns of gliadin-and astrovirus-specific CD4+ T cells isolated in parallel from the small intestine of celiac disease patients</title>
		<author>
			<persName><forename type="first">Ø</forename><surname>Molberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Lundin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Nilsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Brandtzaeg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Thorsby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sollid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tissue Antigens</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="407" to="415" />
			<date type="published" when="1998">1998a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease</title>
		<author>
			<persName><forename type="first">Ø</forename><surname>Molberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Macadam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Korner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Quarsten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Madsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fugger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Noren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roepstorff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E A</forename><surname>Lundin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sjøstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sollid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="713" to="717" />
			<date type="published" when="1998">1998b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Is Alzheimer&apos;s disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="1171" to="1173" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Assembly of fibronectin into extracellular matrix</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Mosher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Fogerty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Chernousov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Barry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. N.Y. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">614</biblScope>
			<biblScope unit="page" from="167" to="180" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Cross-linking of fibronectin to collagenous proteins</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Mosher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Biochem</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="63" to="68" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">A novel pathway for secretary proteins?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Muesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hartmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rohde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rubartelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sitia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Rapoport</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Biochem. Sci</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="86" to="88" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Cross-linking sites of the human tau protein, probed by reactions with human transglutaminase</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Murthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Lukas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kuret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lorand</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="2607" to="2614" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Coeliac disease in the West of Ireland</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mylotte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Egan-Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Mccarthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mcnicholl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. Med. J</title>
		<imprint>
			<biblScope unit="volume">878</biblScope>
			<biblScope unit="page" from="498" to="499" />
			<date type="published" when="1973">1973</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed &apos;cementoin&apos;</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ghoneim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tachibana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hirose</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biochem. (Tokyo)</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="441" to="448" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Bricks and mortar of the epidermal barrier</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Nemes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp. Mol. Med</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="5" to="19" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Nemes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Adany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Balazs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fesus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="page" from="20577" to="20583" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main">A novel function for the transglutaminase 1 enzyme: attachment of long chain v-hydroxyceramides to involucrin by ester bond formation</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Nemes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Marekov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fesus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl. Acad. Sci. USA 96</title>
				<meeting>Natl. Acad. Sci. USA 96</meeting>
		<imprint>
			<date type="published" when="1999">1999</date>
			<biblScope unit="page" from="8402" to="8407" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Nilsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Jahnsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Lundin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Johansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Fausa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sollid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jahnsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Brandtzaeg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="551" to="563" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main">Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors</title>
		<author>
			<persName><forename type="first">T</forename><surname>Not</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Horvath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Partanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hammed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Magazzu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fasano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand. J. Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="494" to="498" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main">Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Orr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Banfi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Kwiatkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Servadio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Beaudet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Mccall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Duvick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Ranum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Zoghbi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="221" to="226" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1</title>
		<author>
			<persName><forename type="first">T</forename><surname>Orth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gerken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kellner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Myer Zum Buschenfelde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Mayet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Hepatol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="37" to="47" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main">Mapping of a second locus for lamellar ichthyosis to chromosome 2q33 -35</title>
		<author>
			<persName><forename type="first">L</forename><surname>Parmentier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lakhdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Blanchet-Bardon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marchand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dubertret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weissenbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Mol. Genet</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="555" to="559" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main">Bacterial pro-transglutaminase from Strepto6erticillium mobaraense-purification, characterisation and sequence of the zymogen</title>
		<author>
			<persName><forename type="first">R</forename><surname>Pasternack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dorsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Otterbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Robenek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Fuchsbauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Biochem</title>
		<imprint>
			<biblScope unit="volume">257</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="570" to="576" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main">Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors</title>
		<author>
			<persName><forename type="first">C</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Goldman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="2758" to="2762" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main">Three novel point mutations in the keratinocyte transglutaminase (TGK) gene in lamellar ichthyosis: significance for mutant transcript level, TGK immunodetection and activity</title>
		<author>
			<persName><forename type="first">E</forename><surname>Petit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rochat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bodemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Teillac-Hamel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Muh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Revuz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Barrandon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lathrop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>De Prost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hovnanian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="218" to="228" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main">Identification of &apos;tissue&apos; transglutaminase binding proteins in neural cells committed to apoptosis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Piredda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Farrace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lo Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Malorni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Melino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Petruzzelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piacentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="355" to="364" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main">Mutation in the a-synuclein gene identified in families with Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Polymeropoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lavedan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Leroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Ide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dehejia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dutra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Root</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rubenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Boyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Stenroos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chandrasekharappa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Athanassiadou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Papapetropoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Lazzarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Duvoisin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Iorio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Golbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Nussbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="2045" to="2047" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main">Cereal dietary proteins with sites for cross-linking by transglutaminase</title>
		<author>
			<persName><forename type="first">R</forename><surname>Porta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gentile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Esposito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mariniello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Auricchio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Phytochemistry</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2801" to="2804" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main">Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Pulst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nechiporuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nechiporuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gispert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">N</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lopes-Cendes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pearlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Starkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Orozco-Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lunkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dejong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Rouleau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Auburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Korenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Figueroa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sahba</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="269" to="276" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main">Osteopontin, a substrate for transglutaminase and factor XIII activity</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Prince</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dickie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Krumdieck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="1205" to="1210" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main">Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase</title>
		<author>
			<persName><forename type="first">M</forename><surname>Raghunath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hopfner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aeschlimann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Luthi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Meuli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Altermatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gobet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bruckner-Tuderman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Steinmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="1174" to="1184" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main">Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalyzed homopolymerization and cross-linking to alpha 2M receptor</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Sorensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gliemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Jensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">338</biblScope>
			<biblScope unit="page">161166</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main">Diseases associated with dermatitis herpetiformis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Reunala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Collin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Dermatol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="315" to="318" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main">Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Rider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Gurley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Garcia De La Torre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Kalovidouris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>O'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Hennekam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Baumbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Neville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klingman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gibbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Weisman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Targoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="710" to="719" />
			<date>19987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b174">
	<analytic>
		<title level="a" type="main">Genetic dissection of familial Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">O</forename><surname>Riess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kruger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Med. Today</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="438" to="444" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b175">
	<analytic>
		<title level="a" type="main">Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ritchie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Lawrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Crombie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Mosesson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Booth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="24915" to="24920" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main">Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Romanic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Arleth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Willette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Ohlstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ. Res</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="264" to="269" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b177">
	<analytic>
		<title level="a" type="main">Participation of transglutaminase in the activation of latent transforming growth factor beta 1 in aging articular cartilage</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Rosenthal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Gohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Le</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1729" to="1733" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main">Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Digiovanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hashem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Compton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Bale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="279" to="283" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title level="a" type="main">Occurrence of IgA and IgG autoantibodies to calreticulin in coeliac disease and various autoimmune diseases</title>
		<author>
			<persName><forename type="first">D</forename><surname>Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tuckova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sebo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Michalak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Whelan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sterzl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jelinkova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Havrdova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Imramovska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Benes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Krupickova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tlaskalova-Hogenova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Autoimmun</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="441" to="449" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b180">
	<analytic>
		<title level="a" type="main">A human lens model of cortical cataract: Ca ++ -induced protein loss, vimentin cleavage and opacification</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sanderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Marcantonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Duncan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Invest. Opthalmol. Vis. Sci</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="2255" to="2261" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main">The incidence of endemic sprue/celiac disease in Berlin (West). A prospective study with short discussion of a case</title>
		<author>
			<persName><forename type="first">F</forename><surname>Sandforth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Janicke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Luders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Niedobietek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Stolpmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Riecken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Z. Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="327" to="332" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b182">
	<analytic>
		<title level="a" type="main">Vitronectin is a substrate for transglutaminases</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Sane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Pippen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Achyuthan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Greenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="115" to="120" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b183">
	<analytic>
		<title level="a" type="main">Hutingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions</title>
		<author>
			<persName><forename type="first">F</forename><surname>Saudou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Finkbeiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Devys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Greenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="55" to="66" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main">Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Wiegand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Margolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lawler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Greenamyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1194" to="1198" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b185">
	<analytic>
		<title level="a" type="main">Identification of the autoantigen of coeliac disease</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schuppan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ehnis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Volta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Donner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Riecken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Dieterich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. N. Y. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">859</biblScope>
			<biblScope unit="page" from="121" to="126" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b186">
	<analytic>
		<title level="a" type="main">Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ihara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="6070" to="6074" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b187">
	<analytic>
		<title level="a" type="main">Splice-site mutation in TGM1 in congenital recessive ichthyosis in American families: molecular, genetic, genealogic, and clinical studies</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">O</forename><surname>Shevchenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Compton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Toro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Digiovanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Bale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="492" to="499" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b188">
	<analytic>
		<title level="a" type="main">Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sjostrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Lundin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Molberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Korner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Mcadam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Anthonsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Quarsten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Noren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roepstorff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Thorsby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sollid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="111" to="115" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b189">
	<analytic>
		<title level="a" type="main">Alpha-synuclein in Lewy bodies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Spillantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Trojanowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="839" to="840" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b190">
	<analytic>
		<title level="a" type="main">Localization of transglutaminase-reactive glutamine residues in bovine osteopontin</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Sorensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Moller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hojrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Petersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">304</biblScope>
			<biblScope unit="page" from="13" to="16" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b191">
	<analytic>
		<title level="a" type="main">A founder effect is proposed for factor XIII B subunit deficiency caused by the insertion of triplet AAC in exon III encoding the second sushi domain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Souri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Izumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Higashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Girolami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ichinose</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thromb. Haemost</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="211" to="213" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b192">
	<analytic>
		<title level="a" type="main">The complexity and redundancy of epithelial barrier function</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell. Biol</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="F5" to="F7" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b193">
	<analytic>
		<title level="a" type="main">Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Marekov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Biol. Cell</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="4247" to="4261" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b194">
	<analytic>
		<title level="a" type="main">Biochemical evidence that small proline rich proteins and trichohyalin function in epithelia to modulate the biomechanical properties of their cornified cell envelopes</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steinert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kartasova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Marekov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="page" from="11758" to="11769" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b195">
	<analytic>
		<title level="a" type="main">Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias</title>
		<author>
			<persName><forename type="first">G</forename><surname>Stevanin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Trottier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cancel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Durr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Didierjean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Burk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Imbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Saudou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abada-Bendib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gourfinkel-An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Benomar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Klockgether</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Agid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Mandel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brice</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Mol. Genet</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1887" to="1892" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b196">
	<analytic>
		<title level="a" type="main">Correlation between the onset age of Huntington&apos;s disease and length of the trinucleotide repeat in IT-15</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">C</forename><surname>Stine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pleasant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Franz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Abbott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Folstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Mol. Genet</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1547" to="1549" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b197">
	<analytic>
		<title level="a" type="main">Molecular mechanism of type II factor XIII deficiency: novel G562R mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system</title>
		<author>
			<persName><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tsukamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Umeyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="2830" to="2838" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b198">
	<analytic>
		<title level="a" type="main">Cross -linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor</title>
		<author>
			<persName><forename type="first">T</forename><surname>Tamaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Aoki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">661</biblScope>
			<biblScope unit="page" from="280" to="286" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b199">
	<analytic>
		<title level="a" type="main">Differential pattern in tissue-specific somatic mosaicism of expanded CAG trinucleotide repeats in dentatorubral-pallidoluysian atrophy, Machado -Joseph disease, and X-linked recessive spinal and bulbar muscular atrophy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sobue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Doyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shimada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Riku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hshizume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mitsuma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurol. Sci</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="43" to="50" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b200">
	<analytic>
		<title level="a" type="main">The Huntington&apos;s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&apos;s Disease chromosomes</title>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="971" to="983" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b201">
	<analytic>
		<title level="a" type="main">Celiac sprue</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Trier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="1709" to="1719" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b202">
	<analytic>
		<title level="a" type="main">Epidermal transglutaminase in the ichthyoses</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Van Hooijdonk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Steijlen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bergers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Mier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Traupe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Happle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta. Derm. Venereol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="173" to="175" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b203">
	<analytic>
		<title level="a" type="main">Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Van De Wal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kooy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Veelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mearin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Papadopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Koning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="1585" to="1588" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b204">
	<analytic>
		<title level="a" type="main">The unstable trinucleotide repeat story of major psychosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Petronis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Kennedy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Med. Genet</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="77" to="97" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b205">
	<analytic>
		<title level="a" type="main">Huntington disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Vonsattel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Difiglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="369" to="384" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b206">
	<analytic>
		<title level="a" type="main">CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wajgt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gorny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurol. Scand</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="337" to="343" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b207">
	<analytic>
		<title level="a" type="main">Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Wellington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Singaraja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ellerby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Savill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Leavitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cattaneo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hackam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Thornberry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Nicholson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Bredesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hayden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="19831" to="19838" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b208">
	<analytic>
		<title level="a" type="main">Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Weinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Pippen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Greenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis. Rheum</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="996" to="1000" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b209">
	<analytic>
		<title level="a" type="main">Homozygotes for Huntington&apos;s disease</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Wexler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Tanzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Travers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Starosta-Rubinstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Penney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Snodgrass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Shoulson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ramos Arroyo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">326</biblScope>
			<biblScope unit="page" from="194" to="197" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b210">
	<analytic>
		<title level="a" type="main">Degradation of tryptophan in neurodegenerative disorders</title>
		<author>
			<persName><forename type="first">B</forename><surname>Widner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leblhuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Walli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Tilz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Demel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fuchs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv. Exp. Med. Biol</title>
		<imprint>
			<biblScope unit="volume">467</biblScope>
			<biblScope unit="page" from="133" to="138" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b211">
	<analytic>
		<title level="a" type="main">Increased transglutaminase in the aortas of cholesterol-fed rabbits: occurrence of buffer soluble and insoluble forms and an inhibitor</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I</forename><surname>Wiebe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Tarr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bowness</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Cell. Biol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="821" to="827" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b212">
	<analytic>
		<title level="a" type="main">Lewy body variant of Alzheimer&apos;s disease: alpha-synuclein in dystrophic neurites of A beta plaques</title>
		<author>
			<persName><forename type="first">O</forename><surname>Wirths</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Majtenyi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Havas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Kahle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Okochi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Haass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Multhaup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyreuther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Bayer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="3737" to="3741" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b213">
	<analytic>
		<title level="a" type="main">Tissue transglutaminase is an in situ substrate of calpain: regulation of activity</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Guttmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="240" to="247" />
			<date type="published" when="1998">1998a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b214">
	<analytic>
		<title level="a" type="main">Modulation of the in situ activity of tissue transglutaminase by calcium and GTP</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lesort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Guttmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="page" from="2288" to="2295" />
			<date type="published" when="1998">1998b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b215">
	<analytic>
		<title level="a" type="main">Differentiation and programmed cell death-related intermediate biomarkers for the development of non-small cell lung cancer: a pilot study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Yousem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Elder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Landreneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ferson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Keenan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Whiteside</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Levitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Pathol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="965" to="971" />
			<date type="published" when="1998">1998c</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b216">
	<analytic>
		<title level="a" type="main">Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Zemaitaitis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Troncoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Muma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="983" to="989" />
			<date type="published" when="2000">2000a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b217">
	<analytic>
		<title level="a" type="main">Expression of the transglutaminase enzymes in progressive supranuclear palsy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Zemaitaitis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Muma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Soc. Neurosci. Abstr</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page">1555</biblScope>
			<date type="published" when="2000">2000b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b218">
	<analytic>
		<title level="a" type="main">Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltagedependent calcium channel</title>
		<author>
			<persName><forename type="first">O</forename><surname>Zhuchenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bonnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ashizawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Stockton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Amos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Dobyns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Subramony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Zoghbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="62" to="69" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
